0001493152-20-015308.txt : 20200812 0001493152-20-015308.hdr.sgml : 20200812 20200812091620 ACCESSION NUMBER: 0001493152-20-015308 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 53 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ScoutCam Inc. CENTRAL INDEX KEY: 0001577445 STANDARD INDUSTRIAL CLASSIFICATION: OPTICAL INSTRUMENTS & LENSES [3827] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-188920 FILM NUMBER: 201094332 BUSINESS ADDRESS: STREET 1: 14201 N. HAYDEN ROAD, SUITE A-1 CITY: SCOTTSDALE STATE: AZ ZIP: 85260 BUSINESS PHONE: 480-659-6404 MAIL ADDRESS: STREET 1: 14201 N. HAYDEN ROAD, SUITE A-1 CITY: SCOTTSDALE STATE: AZ ZIP: 85260 FORMER COMPANY: FORMER CONFORMED NAME: Intellisense Solutions Inc. DATE OF NAME CHANGE: 20130521 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2020

 

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                   to

 

Commission File No. 333-188920

 

SCOUTCAM INC.
(Exact name of registrant as specified in its charter)

 

Nevada   847-4257143

(State or other jurisdiction

of incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

Suite 7A, Industrial Park    
P.O. Box 3030, Omer, Israel    8496500
(Address of Principal Executive Offices)   (Zip Code)

 

+972 72 260-2200
(Registrant’s telephone number, including area code)

 

 
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

[  ] Large accelerated filer [  ] Accelerated filer
[X] Non-accelerated filer [X] Smaller reporting company
    [  ] Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

As of June 30, 2020, the registrant had 33,764,128 shares of common stock, par value $0.001, of the registrant issued and outstanding.

 

As used in this Quarterly Report and unless otherwise indicated, the terms “ScoutCam,” “we,” “us,” “our,” or “our Company” refer to ScoutCam Inc. Unless otherwise specified, all dollar amounts are expressed in United States dollars.

 

 

 

   
 - 2 - 

 

SCOUTCAM INC.

 

QUARTERLY REPORT ON FORM 10-Q

 

TABLE OF CONTENTS

 

  Page
   
Cautionary Note Regarding Forward-Looking Statements 3
   
PART 1-FINANCIAL INFORMATION  
     
Item 1. Consolidated Financial Statements (unaudited) 4
     
  Consolidated Balance Sheets 5
     
  Consolidated Statements of Comprehensive Loss 7
     
  Statements of Stockholders’ Equity 8
     
  Consolidated Statements of Cash Flows 10
     
  Notes to Consolidated Financial Statements 11
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk 26
     
Item 4. Control and Procedures 26
   
PART II-OTHER INFORMATION  
     
Item 1A. Risk Factors 27
     
Item 6. Exhibits 28
   
SIGNATURES 29

 

   
 - 3 - 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information set forth in this Quarterly Report on Form 10-Q, including in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere herein may address or relate to future events and expectations and as such constitutes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events.

 

Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” or “project” or the negative of these words or other variations on these words or comparable terminology. Actual results, performance, liquidity, financial condition and results of operations, prospects and opportunities could differ materially and perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties and other factors. These statements may be found under the section of our Annual Report on Form 10-K for the year ended December 31, 2019 (filed on March 16, 2020) entitled “Risk Factors” as well as in our other public filings.

 

In light of these risks and uncertainties, and especially given the start-up nature of our business, there can be no assurance that the forward-looking statements contained herein will in fact occur. Readers should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason.

 

   
 - 4 - 

 

SCOUTCAM INC.

INTERIM FINANCIAL STATEMENTS

AS OF JUNE 30, 2020

 

 

 

SCOUTCAM INC.

 

  Page
Interim Financial Statements – in US Dollars (USD) in thousands  
Interim Condensed Consolidated Balance Sheets (unaudited) 5
Interim Condensed Consolidated Statements of Operations (unaudited) 7
Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity (unaudited) 8
Interim Condensed Consolidated Statements of Cash Flows (unaudited) 10
Notes to the Interim Condensed Consolidated Financial Statements 11

 

   
 - 5 - 

 

SCOUTCAM INC.

 

INTERIM CONDENSED CONSOLIATED BALANCE SHEETS

 

    June 30,     December 31,  
    2020     2019  
    Unaudited     Audited  
    USD in thousands  
Assets                
                 
CURRENT ASSETS:                
Cash and cash equivalents     3,608       3,245  
Accounts receivables     26       22  
Inventory     1,239       900  
Parent company     143       73  
Other current assets     332       78  
      5,348       4,318  
                 
NON-CURRENT ASSETS:                
Property and equipment, net     253       59  
Operating lease right-of-use assets     94       53  
Severance pay asset     314       327  
      661       439  
                 
TOTAL ASSETS     6,009       4,757  

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

   
 - 6 - 

 

SCOUTCAM INC.

 

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

 

    June 30,     December 31,  
    2020     2019  
    Unaudited     Audited  
    USD in thousands  
Liabilities and shareholders’ equity                
                 
CURRENT LIABILITIES:                
Accounts payables     168       35  
Loan from Parent company     -       500  
Contract liabilities     672       502  
Operating lease liabilities - short term     43       24  
Accrued compensation expenses     333       297  
Other accrued expenses     196       552  
      1,412       1,910  
NON-CURRENT LIABILITIES:                
Operating lease liabilities - long term     51       29  
Liability for severance pay     297       296  
      348       325  
TOTAL LIABILITIES     1,760       2,235  
                 
SHAREHOLDERS’ EQUITY:                
Ordinary shares Common stock, $0.001 par value; 75,000,000 shares authorized, 33,764,128 and 26,884,921 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively     34       27  
Additional paid-in capital     8,238       4,135  
Accumulated deficit     (4,023)       (1,640 )
TOTAL SHAREHOLDERS’ EQUITY     4,249       2,522  
                 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY     6,009       4,757  

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

   
 - 7 - 

 

SCOUTCAM INC.

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

   Six months ended   Three months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
   Unaudited 
   USD in thousands (except per share data) 
Revenues:                    
Products   74    59    34    35 
Services   -    85    -    85 
    74    144    34    120 
Cost of revenues:                    
Products   281    219    151    110 
Services   -    85    -    85 
    281    304    151    195 
                     
Gross Loss   (207)   (160)   (117)   (75)
Research and development expenses   370    141    115    54 
Sales and marketing expenses   188    84    136    43 
General and administrative expenses   1,680    292    568    176 
Operating loss   (2,445)   (677)   (936)   (348)
Financing income (expenses), net   62    (14)   (34)   (14)
Net Loss   (2,383)   (691)   (970)   (362)

Net loss per ordinary share (basic and

diluted, USD)

   (0.08)   (0.04)   (0.03)   (0.02)

Weighted average ordinary shares (basic

and diluted, in thousands)

   29,185    16,131    30,880    16,131 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

   
 - 8 - 

 

SCOUTCAM INC.

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

 

Six Months Ended June 30, 2020

 

   Ordinary shares   Additional paid-in   Accumulated   Total Shareholders’ 
   Number   Amount   capital   deficit   equity 
   in thousands   USD in thousands 
Balance at January 1, 2020   26,885   $27    4,135    (1,640)   2,522 
Issuance of shares and warrants   6,092   $6    2,852    -    2,858 
Stock based compensation   -    -    871    -    871 
Conversion of a loan from Parent company   787   $1    380    -    381 
Net loss   -    -    -    (2,383)   (2,383)
                          
Balance at June 30, 2020   33,764   $34    8,238    (4,023)    4,249 

 

Three Months Ended June 30, 2020

 

   Ordinary shares   Additional paid-in   Accumulated   Total Shareholders’ 
   Number   Amount   capital   deficit   Equity 
   in thousands   USD in thousands 
Balance at April 1, 2020   28,845   $29    5,743    (3,053)   2,719 
Issuance of shares and warrants   4,132    4    1,945    -    1,949 
Stock based compensation   -    -    170    -    170 
Conversion of a loan from Parent company   787   $1    380    -    381 
Net loss   -    -    -    (970)   (970)
                          
Balance at June 30, 2020   33,764   $34    8,238    (4,023)    4,249 

 

   
 - 9 - 

 

SCOUTCAM INC.

 

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

 

Six Months Ended June 30, 2019

 

   Ordinary shares   Additional paid-in   Parent company   Accumulated   Total Shareholders’ 
   Number   Amount   capital   deficit   deficit   Equity 
   in thousands  

USD in thousands

 
Balance at January 1, 2019   16,131    16    (16)   (118)   -    (118)
Capital contribution from Parent company   -    -    467    -    -    467 
Consummation of the Carve-out   -    -    207    (207)   -    - 
Stock based compensation   -    -    3    -    -    3 
Net transfer from Parent company   -    -    -    514    -    514 
Net loss   -    -    -    (189)   (502)   (691)
                               
Balance at June 30, 2019   16,131    16    661    -    (502)   175 

 

 

Three Months Ended June 30, 2019

 

   Ordinary shares   Additional paid-in   Parent company   Accumulated   Total Shareholders’ 
   Number   Amount   capital   deficit   deficit   Equity 
   in thousands  

USD in thousands

 
Balance at April 1, 2019   16,131    16    281    -    (140)   157 
Capital contribution from Parent company   -    -    377    -    -    377 
Stock based compensation   -    -    3    -    -    3 
Net loss   -    -    -    -    (362)   (362)
                               
Balance at June 30, 2019   16,131    16    661    -    (502)   175 

 

 

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

 

   
 - 10 - 

 

SCOUTCAM INC.

 

INTERIM CONDENSED CONOLIDATED STATEMENTS OF CASH FLOWS

 

    Six months ended     Three months ended  
    June 30,     June 30,  
    2020     2019     2020     2019  
    Unaudited  
    USD in thousands  
                         
CASH FLOWS FROM OPERATING ACTIVITIES:                                
Net loss     (2,383 )     (691 )     (970 )     (362 )
Adjustments to reconcile net loss to net cash used in operations:                                
Depreciation     27       1       16       -  
Other non-cash items     14       19       (25 )     -  
Share based compensation     837       -       155       -  
Loss (Profit) from exchange differences on cash and cash equivalents     (84 )     -       12       -  
                                 
CHANGES IN OPERATING ASSET AND LIABILITY ITEMS:                                
Accounts receivable     (4 )     73       (14 )     (14 )
Inventory     (302 )     (309 )     (177 )     (91 )
Parent company     (111 )     (102 )     (95 )     (26 )
Other current assets     (254 )     (87 )     (201 )     (116 )
Accounts payables     133       87       128       105  
Contract liabilities     170       5       126       5  
Accrued compensation expenses     36       88       60       80  
Other accrued expenses     (356 )     17       (155 )     34  
Net cash flows used in operating activities     (2,277 )     (899 )     (1,140 )     (385 )
                                 
CASH FLOWS FROM INVESTING ACTIVITIES:                                
                                 
Purchase of property and equipment     (221 )     -       (36 )     -  
Net cash flows used in investing activities     (221 )     -       (36 )     -  
                                 
CASH FLOWS FROM FINANCING ACTIVITIES:                                
Loan repayment to Parent company     (81 )     -       -       -  
Transfer from Parent company     -       514       -       377  
Capital Contribution from Parent company     -       467       -       -  
Proceeds from issuance of shares and warrants     2,858       -       1,949       -  
Net cash flows provided by financing activities     2,777       981       1,949       377  
                                 
PROFIT (LOSS) FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS     84       -       (12 )     -  
                                 
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS     363       82       761       (8 )
BALANCE OF CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD     3,245       -       2,847       90  
BALANCE OF CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD     3,608       82       3,608       82  

 

Non cash activities - 

 

   Six months ended   Three months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
   Unaudited 
   USD in thousands 
Parent Company loan settled against Parent Company receivable   41    -    -    - 
Conversion of a loan from Parent company   381    -    381    - 

 

   
 - 11 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL:

 

  a.

ScoutCam Inc. (the “Company”), formally known as Intellisense Solutions Inc. (“Intellisense”), was incorporated under the laws of the State of Nevada on March 22, 2013 under the name Intellisense Solutions Inc. The Company was initially engaged in the business of developing web portals to allow companies and individuals to engage in the purchase and sale of vegetarian food products over the Internet. The Company was unable to execute its original business plan, develop significant operations or achieve commercial sales. Prior to the closing of the Securities Exchange Agreement (as defined below), the Company was a “shell company”.

 

ScoutCam Ltd. (the “Subsidiary”, “ScoutCam”), was formed in the State of Israel on January 3, 2019 as a wholly-owned subsidiary of Medigus Ltd. (the “Parent Company”, “Medigus”), an Israeli company traded both on the Nasdaq Capital Market and the Tel Aviv Stock Exchange, and commenced operations on March 1, 2019. Upon incorporation, the Subsidiary issued to Medigus 1,000,000 Ordinary shares with no par value. On March 2019, the Subsidiary issued to Medigus an additional 1,000,000 Ordinary shares with no par value.

 

The Subsidiary was incorporated as part of a reorganization of Medigus, which was designed to distinguish the Subsidiary miniaturized imaging business, or the micro ScoutCam™ portfolio, from Medigus’s other operations and to enable Medigus to form a separate business unit with dedicated resources focused on the promotion of such technology. In December 2019, Medigus and the Subsidiary consummated a certain Amended and Restated Asset Transfer Agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to the Subsidiary.

 

On September 16, 2019, Intellisense entered into a Securities Exchange Agreement (the “Exchange Agreement”), with Medigus, pursuant to which Medigus assigned, transferred and delivered 100% of its holdings in the Subsidiary to Intellisense, in exchange for consideration consisting of shares of Intellisense’s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the closing of the Exchange Agreement (the “Closing”). The Closing occurred on December 30, 2019 (the “Closing Date”). On December 31, 2019, Intellisense changed its name to ScoutCam Inc.

 

Although the transaction resulted in the ScoutCam becoming a wholly owned subsidiary of Intellisense, the transaction constituted a reverse recapitalization since Medigus, the only shareholder of the ScoutCam prior to the Exchange Agreement, was issued a substantial majority of the outstanding capital stock of Intellisense upon consummation of the Exchange Agreement, and also taking into account that prior to the Closing Date, Intellisense was considered as a shell corporation. Accordingly, the Subsidiary is considered the accounting acquirer of the merged company.

 

The Subsidiary has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam™ 1.2. These innovative cameras are suitable for both medical and industrial applications. Based on its proprietary technology, The Subsidiary designs and manufactures endoscopy and micro camera systems for partner companies.

 

   
 - 12 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – GENERAL (continued):

 

 

b.

 

The accompanying comparative consolidated financial statements include the historical accounts of the Subsidiary as a “Carve-out Business”, a division of Medigus. Throughout the comparative periods included in these Financial Statements, the Carve-out Business operated as part of Medigus. Separate financial statements have not historically been prepared for the Carve-out Business. These comparative carve-out financial data has been prepared on a standalone basis and is derived from Medigus’s consolidated financial statements and accounting records. The carve-out comparative financial data reflects the Subsidiary’s financial position, results of operations, changes in net parent deficit and cash flows in accordance with U.S. GAAP.

 

The financial position, results of operations, changes in net parent deficit, and cash flows of the Carve-out Business may not be indicative of its results had it been a separate stand-alone entity during the comparative periods presented.

 

The comparative carve-out financial data of the Company includes expenses which were allocated from Medigus for certain functions, including general corporate expenses related to corporate strategy, procurement, Information Technology (“IT”), Human Resources (“HR”) and legal. These allocation have been made on the basis of direct usage when identifiable, with the remainder allocated on the basis of headcount. Management believes the expense allocation methodology and results are reasonable and consistently applied for all comparative periods presented. However, these allocations may not be indicative of the actual expenses that would have been incurred by an independent company or of the costs to be incurred in the future.

 

The carve-out comparative financial statements include assets and liabilities specifically attributable to the Carve-out Business. Medigus uses a centralized approach for managing cash and financing operations. Accordingly, a substantial portion of the cash balances are transferred to Medigus’ cash management accounts regularly and therefore are not included in the financial statements. Transfers of cash between Carve-out business and Medigus are included within “Net transfers from Parent company” on the Statements of Cash Flows and the Statements of changes in shareholder’s equity (capital deficiency).

 

As the carve-out comparative financial information has been prepared on a carve-out basis, the amounts reflected in Parent Company deficit in the comparative statement of changes in shareholder’s equity (capital deficiency) refer to net loss for the period attributed to the Subsidiary in addition to transactions between Medigus and the Subsidiary.

     
  c.

During the six month ended June 30, 2020, the Company incurred a loss of USD 2,383 thousand and negative cash flows from operating activities of approximately USD 2,277 thousand. Based on the projected cash flows, the Company’s Management is of the opinion that without further fundraising it will not have sufficient resources to enable it to continue its operating activities including the development, manufacturing and marketing of its products within one year after the issuance date of these financial statements. As a result, there is a substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date of these financial statements.

     
    Management’s plans include continuing commercialization of the Company’s products and securing sufficient financing through the sale of additional equity securities, debt or capital inflows from strategic partnerships and other opportunities. There are no assurances however, that the Company will be successful in obtaining the level of financing needed for its operations. If the Company is unsuccessful in commercializing its products and securing sufficient financing, it may need to reduce activities, curtail or even cease operations.
     
   

These consolidated financial statements have been prepared assuming the Company will continue as a going concern, which assumes the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The accounting policies set out below have, unless otherwise stated, been applied consistently.

     
  d. The coronavirus (“COVID-19”), which was declared in March 2020 by the World Health Organization as a pandemic, has had a significant impact on global markets and the economy of many countries, including countries in which the Company operates. As the ultimate impact on the global economy of the COVID-19 pandemic remains unclear, the Company anticipates that it will have a continuing impact on global economies in the near future. While the COVID-19 pandemic has not materially affected the Company’s operations as of the date hereof, the extent to which the COVID-19 pandemic shall impact the Company’s operations will depend on future developments. In particular, the continued spread of COVID-19 globally could materially adversely impact the Company’s operations and workforce, including its manufacturing activities, product sales, as well as its ability to continue to raise capital. Travel restrictions could materially adversely impact our sales and marketing and research and development efforts.

 

   
 - 13 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

  A. Unaudited Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

 

  B. Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

  C. Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.

 

  D. Significant Accounting Policies

 

The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.

 

  E. Recently Adopted Accounting Pronouncement

 

The significant accounting policies followed in the preparation of these unaudited interim consolidated financial statements are identical to those applied in the preparation of the latest annual audited financial statements with the exception of the following:

 

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments – Credit Losses” to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. The ASU replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. The Company adopted this ASU on January 1, 2020. There was not a material impact on the interim consolidated financial statements.

 

In August 2018, the FASB issued ASU 2018-13, “Changes to Disclosure Requirements for Fair Value Measurements,” which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements and is effective for the Company beginning on January 1, 2020. This standard did not have a material effect on the Company’s interim consolidated financial statements.

 

In November 2018, the FASB issued ASU 2018-18 – “Collaborative Arrangements (Topic 808),” which clarifies the interaction between Topic 808 and Topic 606, Revenue from Contracts with Customers. The Company adopted this standard in the first quarter of fiscal year 2020. This standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

 

  F. Recent Accounting Pronouncements

 

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. The Company does not expect that the adoption of this standard will have a significant impact on the consolidated financial statements and related disclosures.

 

   
 - 14 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 – LEASES:

 

On January 1, 2019, the Company adopted ASU 2016-02 using the modified retrospective approach for all lease arrangements at the beginning period of adoption. The Subsidiary leases office and vehicles under operating leases. On June 30, 2020, the Company’s ROU assets and lease liabilities for operating leases totalled $94 thousand.

 

In January 2020, the Subsidiary entered into a lease agreement for office space in Omer, Israel. The agreement is for 11 months beginning on February 1, 2020. Monthly lease payments under the agreement are approximately $6 thousand. Lease expenses recorded in the interim consolidated statements of operations were $31 thousand for the six months ended June 30, 2020. The Company has elected the short-term lease exception for this lease. As part of this election it will not recognize right-of-use assets and lease liabilities on the balance sheet for this lease.

 

Supplemental cash flow information related to operating leases was as follows:

 

   

Six months ended

June 30, 2020

  
    USD in thousands  
Cash payments for operating leases     23  
Cash payments for short-term lease     31  
Total lease expenses     54  

 

As of June 30, 2020, the Company’s operating leases had a weighted average remaining lease term of 1.9 years and a weighted average discount rate of 10%. Future lease payments under operating leases as of June 30, 2020 are as follows:

 

    Operating leases  
    USD in thousands  
Remainder of 2020     23  
2021     45  
2022     38  
Total future lease payments     106  
Less imputed interest     (12 )
Total lease liability balance     94  

 

   
 - 15 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – EQUITY:

 

Private placement:

 

  a. In December 2019, the Company allotted in a private issuance, a total of 3,413,312 units at a purchase price of USD $0.968 per unit. Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below). The immediate proceeds (gross) from the issuance of the units amounted to approximately USD 3.3 million.

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 month period following the allotment. Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 month period following the allotment.

 

In addition, Shrem Zilberman Group Ltd. (the “Consultant”) will be entitled to receive the amount representing 3% of any exercise price of each Warrant A or Warrant B that may be exercised in the future. In the event the total proceeds received as a result of exercise of Warrants will be less than $2 million at the time of their expiration, the Consultant will be required to invest $250,000 in the Company in return for shares of common stock of Company.

 

  b. On March 3, 2020, the Company allotted in a private issuance a total of 979,754 units at a purchase price of USD $0.968 per unit.

 

Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below).

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 month period following the allotment.

 

Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 month period following the allotment.

 

The immediate proceeds (gross) from the issuance of all securities offered amounted to approximately USD 948 thousands. After deducting closing costs and fees, the Company received proceeds of approximately USD 909 thousand, net of issuance expenses.

 

c. On May 18, 2020, the Company allotted in a private issuance a total of 2,066,116 units at a purchase price of USD $0.968 per unit.

 

Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below).

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 18 month period following the allotment.

 

Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 24 month period following the allotment.

 

The immediate proceeds (gross) from the issuance of all securities offered amounted to approximately USD 2 million. After deducting closing costs and fees, the Company received proceeds of approximately USD 1.9 million, net of issuance expenses.

 

d.

On June 23, 2020, (the “Conversion Date”) the Company entered into and consummated a Side Letter Agreement with Medigus, whereby the parties agreed to convert, at a conversion price of $0.484, an outstanding line of credit previously extended by Medigus to the Subsidiary, which as of the Conversion Date was $381,136, into (a) 787,471 shares of the Company’s common stock, (b) warrants to purchase 393,736 shares of common stock with an exercise price of $0.595 (Warrant A), and (c) warrants to purchase 787,471 shares of common stock with an exercise price of $0.893 (Warrant B).

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 months period following the allotment.

 

Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 months period following the allotment. 

 

 

As of June 30, 2020, the Company had the following outstanding warrants to purchase Common Stock as follows:

 

Warrant  Issuance Date  Expiration Date  Exercise Price Per Share ($)   Number of Shares of Common Stock Underlying Warrants 
Warrant A  December 30, 2019  December 30, 2020   0.595    3,413,317 
Warrant B  December 30, 2019  June 30, 2021   0.893    6,826,623 
Warrant A  March 3, 2020  March 3, 2021   0.595    979,754 
Warrant B  March 3, 2020  September 3, 2021   0.893    1,959,504 
Warrant A  May 18, 2020  November 18, 2021   0.595    2,066,116 
Warrant B  May 18 2020  May 18, 2022   0.893    4,132,232 
Warrant A  June 23, 2020  June 23, 2021   0.595    393,736 
Warrant B  June 23,2020  December 23, 2021   0.893    787,471 
               20,558,753 

 

   
 - 16 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – EQUITY (continued):

 

Share-based compensation to employees and to directors:

 

In February 2020, the Company’s Board of Directors approved the 2020 Share Incentive Plan (the “Plan”). The Plan initially included a pool of 5,228,007 shares of common stock for grant to Company employees, consultants, directors, and other service providers. On March 15, 2020, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 576,888 shares of Common Stock. On June 22, 2020, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 3,617,545 shares of Common Stock.

 

The Plan is designed to enable the Company to grant options to purchase ordinary shares and RSUs under various and different tax regimes including, without limitation: (i) pursuant and subject to Section 102 of the Israeli Tax Ordinance or any provision which may amend or replace it and any regulations, rules, orders or procedures promulgated thereunder and to designate them as either grants made through a trustee or not through a trustee; and (ii) pursuant and subject to Section 3(i) of the Israeli Tax Ordinance.

 

On February 12, 2020, the Company granted 4,367,515 options pursuant to the Plan. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.

 

On March 15, 2020, the Company granted 576,888 options pursuant to the Plan to each of the Company’s then serving directors, excluding Professor Benad Goldwasser. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.

 

On June 22, 2020, the Company granted 1,544,769 options pursuant to the Plan to Company employees, consultants, directors. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.

 

The fair value of each option was estimated as of the grant date or reporting period using the Black-Scholes option-pricing model, using the following assumptions:

 

  

Six months ended

June 30, 2020

 
Underlying value of ordinary shares ($)   0.475 
Exercise price ($)   0.29 
Expected volatility (%)   43.91 
Term of the options (years)   7 
Risk-free interest rate (%)   1.25 

 

The cost of the benefit embodied in the options granted during the six months ended June 30, 2020, based on their fair value as at the grant date, is estimated to be approximately $3.3 million. These amounts will be recognized in statements of operations over the vesting period.

 

   
 - 17 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – EQUITY (continued):

 

The following table summarizes stock option activity for the six months ended June 30, 2020:

 

   

For the

Six months ended

June 30, 2020

  
    Amount of options     Weighted average exercise price  
              $  
Outstanding at beginning of period     -       -  
Granted     6,489,172       0.29  
Outstanding at end of period     6,489,172       0.29  
                 
Vested at end of period     1,203,237       0.29  

 

The following table sets forth the total share-based payment expenses resulting from options granted, included in the statements of operation:

 

   

Six months ended

June 30, 2020

  
    USD in thousands  
Research and development     120  
General and administrative     717  
Total expenses     837  

 

   
 - 18 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 5 – REVENUES:

 

Contract liabilities: 

 

The Company’s contract liabilities as of June 30, 2020 and December 31, 2019 were as follows:

 

    June 30,     December 31,  
    2020     2019  
    USD in thousands  
Contract liabilities     672       502  

 

Contract liabilities include advance payments, which are primarily related to advanced billings for development services.

 

Remaining Performance Obligations

 

Remaining Performance Obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of June 30, 2020, the total RPO amounted to $900 thousand, which the Company expects to recognize during the next 12 months.

 

NOTE 6 – INVENTORY

 

Composed as follows:

 

    June 30,     December 31,  
    2020     2019  
    USD in thousands  
Raw materials and supplies     20       24  
Work in progress     647       316  
Finished goods     572       560  
      1,239       900  

 

During the period ended June 30, 2020, no impairment occurred.

 

   
 - 19 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 7 – LOSS PER SHARE

 

Basic loss per share is computed by dividing net loss attributable to ordinary shareholders of the Company, by the weighted average number of ordinary shares as described below.

 

In computing the Company’s diluted loss per share, the numerator used in the basic loss per share computation is adjusted for the dilutive effect, if any, of the Company’s potential shares of common stock. The denominator for diluted loss per share is a computation of the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period.

 

The loss per share information in these consolidated financial statements is reflected and calculated as if the Company had existed since January 1, 2019. Accordingly, loss per share for all periods was calculated based on the number of shares retroactively adjusted for the exchange ratio determined in the reverse recapitalization.

 

NOTE 8 – RELATED PARTIES

 

On May 30, 2019, the Subsidiary entered into an intercompany agreement with Medigus (the “Intercompany Agreement”) according to which the Subsidiary agreed to hire and retain certain services from Medigus. The agreed upon services provided under the Intercompany Agreement included: (1) lease of office space and clean room based on actual space utilized by the Subsidiary and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (4) external accountant services at a price of USD 6,000 per annum; (5) directors and officers insurance at a sum of 1/3 of Parent company cost; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (8) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense

 

In addition, the Subsidiary’s employees provide support services to Medigus.

 

On April 20, 2020, the Subsidiary entered into an amended and restated intercompany services agreement with Medigus. The agreed upon services provided under the amended and restated Intercompany Agreement included:

 

1) lease of office space based on actual space utilized by the Parent Company and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (5) directors and officers insurance the Parent Company shall pay $150,000 of the annual premium.; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (7) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense

 

Balances with related parties:

 

   June 30, 2020   December 31, 2019 
         
Parent Company   143    73 
Loan from Parent Company (see note 4(d))   -    500 

 

Transactions with related parties:

 

   Six months ended June 30, 
   2020   2019 
Revenues   5    - 
Cost of revenues   

5

    - 
Interest payments   8    - 

 

NOTE 9 - SUBSEQUENT EVENTS

 

In accordance with ASC 855 “Subsequent Events” the Company evaluated subsequent events through the date the condensed consolidated financial statements were issued. The Company concluded that no subsequent events have occurred that would require recognition or disclosure in the condensed consolidated financial statements.

 

   
 - 20 - 

 

SCOUTCAM INC.

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

   
 - 21 - 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Readers are advised to review the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the consolidated financial statements and related notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2019. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. See “Cautionary Note Regarding Forward-Looking Statements”. You should review the “Risk Factors” section of our Annual Report for the fiscal year ended December 31, 2019 for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

 

Overview

 

ScoutCam Ltd. (the “Subsidiary”) was formed in Israel on January 3, 2019, as a wholly owned subsidiary of Medigus Ltd., an Israeli company (“Medigus”), and commenced operations on March 1, 2019. The Subsidiary was incorporated as a part of the reorganization of Medigus, which was designed to distinguish the Subsidiary’s miniaturized imaging business, the micro ScoutCam™ portfolio, from Medigus’s other operations and to enable Medigus to form a separate business unit with dedicated resources focused on the promotion of such technology (the “Reorganization”). In December 2019, Medigus and the Subsidiary consummated the Amended and Restated Asset Transfer Agreement, which transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business.

 

On March 1, 2019, 12 employees moved from Medigus to the Subsidiary.

 

The following table summarizes our results of operations for the six month ended June 30, 2020 and 2019, together with the changes in those items in dollars and as a percentage:

 

   2020   2019   % Change 
Revenues   74,000    144,000    (49)%
Cost of Revenues   281,000    304,000    (8)%
Gross Loss   (207,000)   (160,000)   29%
Research and development expenses   370,000    141,000    162%
Sales and marketing expense   188,000    84,000    124%
General and administrative expenses   1,680,000    292,000    475%
Operating Loss   (2,445,000)   (677,000)   261%

 

Revenues

 

For the six months ended June 30, 2020, the Subsidiary generated revenues of $74,000, a decrease of $70,000 from the six months ended June 30, 2019 revenues.

 

The decrease in revenues was primarily due to the fact that during the six month ended June 30, 2019, we recorded revenues for services provided to a customer in the amount of approximately $85,000 (see ‘Customer A’ in note 11b to our financial statements for the year ended December 31, 2019). We did not receive any revenue from services from this customer during the six months ended June 30, 2020.

 

Cost of Revenues

 

Cost of revenues for the six months ended June 30, 2020 were $281,000, a decrease of $23,000 compared to cost of revenues of $304,000 for the six months ended June 30, 2019. The decrease was primarily due to a decrease in materials as a result of a decrease in revenues, partially offset by an increase in payroll expenses as a result of hiring additional employees.

 

Gross Loss

 

Gross loss for the six months ended June 30, 2020 was $207,000, an increase of $47,000 compared to gross loss of $160,000 for the six months ended June 30, 2019.

 

Research and Development Expenses

 

Research and development expenses for the six months ended June 30, 2020, were $370,000, an increase of $229,000, or 162%, compared to $141,000 for the six months ended June 30, 2019. The increase was primarily due to an increase in payroll expenses, as result of an increase in share - based compensation expenses (see note 4 to our interim condensed consolidated financial statements as of June 30, 2020) and hiring additional employees.

 

   
 - 22 - 

 

Sales and Marketing Expenses

 

Sales and marketing expenses for the six months ended June 30, 2020, were $188,000, an increase of $104,000, or 124%, compared to $84,000 for the six months ended June 30, 2019. The increase was primarily due to an increase in marketing activities.

 

General and Administrative Expenses

 

General and Administrative expenses for the six months ended June 30, 2020, were $1,680,000, an increase of $1,388,000, or 475%, compared to $292,000 for the six months ended June 30, 2019. The increase was primarily due to an increase in payroll expenses, as result of an increase in share - based compensation expenses (see note 4 to our interim condensed consolidated financial statements as of June 30, 2020) and hiring additional employees and an increase in professional services. The increase in professional services resulted from the incorporation of the Subsidiary as an independent company and in connection with the execution of that certain securities exchange agreement involving the Subsidiary.

 

Operating loss

 

We incurred an operating loss of $2,445,000 for the six months ended June 30, 2020, an increase of $1,768,000, or 261%, compared to operating loss of $677,000 for the six months ended June 30, 2019. The increase in operating loss was due to $47,000 increase in gross loss, $229,000 increase in research and development expenses, $104,000 increase in sales and marketing expenses and $1,388,000 increase in administrative and general expenses.

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

The Company has financed its operations primarily through Medigus, private placement transactions for the issuance of common stock and warrants, and sales to customers.

 

Cash Flows

 

The following table sets forth the significant sources and uses of cash for the periods set forth below (in dollars):

 

   2020   2019 
Cash used in Operating Activity   (2,277,000)   (899,000)
Cash used in Investing Activity   (221,000)   - 
Cash provided by Financing Activity   2,777,000    981,000 
Profit from exchange differences on cash equivalents   84,000    - 

 

Operating Activities

 

For the six months ended June 30, 2020, net cash flows used in operating activities was $2,277,000, compared to net cash flows used in operating activities of $899,000 for the six months ended June 30, 2019, an increase of $1,378,000. The change was mainly due to an increase in net loss and an increase in other accrued expenses, which was partially offset by an increase in stock-based compensation.

 

   
 - 23 - 

 

Investing Activities

 

For the six months ended June 30, 2020, net cash flows used in investing activities was $221,000 as compared to $0 for the same period of 2019. The change was due to the purchase of property and equipment during the six months ended June 30, 2020.

 

Financing Activities

 

For the six months ended June 30, 2020, net cash flows provided by financing activities was $2,777,000, compared to net cash flows provided by financing activities of $981,000 for six months ended June 30, 2019.

 

Net cash provided by financing activities in the six months ended June 30, 2020 consisted of $2,858,000 in proceeds from the issuance of shares and warrants, and $81,000 in loan repayments from Medigus. Net cash provided by financing activities in the six months ended June 30, 2019 was generated from the transfer of funds from Medigus.

 

Profit from exchange differences on cash equivalents

 

During the six months ended June 30, 2020, the Subsidiary generated profit from exchange differences on cash equivalents of $84,000. This profit represents a change in the Company’s cash and cash equivalents as a result of the change in the dollar exchange rate against the NIS during the six months ended June 30, 2020.

 

The following table summarizes our results of operations for the three months ended June 30, 2020 and 2019, together with the changes in those items in dollars and as a percentage:

 

   2020   2019   % Change 
Revenues   34,000    120,000    (72)%
Cost of Revenues   151,000    195,000    (23)%
Gross Loss   (117,000)   (75,000)   56%
Research and development expenses   115,000    54,000    113%
Sales and marketing expense   136,000    43,000    216%
General and administrative expenses   568,000    176,000    223%
Operating Loss   (936,000)   (348,000)   169%

 

Revenues

 

For the three months ended June 30, 2020, the Subsidiary generated revenues of $34,000, a decrease of $86,000 from the three months ended June 30, 2019 revenues.

 

The decrease in revenues was primarily due to during the three month ended June 30, 2019, we recorded revenues for services provided to a customer in the amount of approximately $85,000 (see ‘Customer A’ in note 11b to our financial statements for the year ended December 31, 2019). We did not receive any revenue from services from this customer during the three months ended June 30, 2020.

 

Cost of Revenues

 

Cost of revenues for the three months ended June 30, 2020 were $151,000, a decrease of $44,000 compared to cost of revenues of $195,000 for the three months ended June 30, 2019. The decrease was primarily due to a decrease in materials as a result of decrease in revenues, partially offset by an increase in payroll expenses as a result of hiring additional employees.

 

Gross Loss

 

Gross loss for the three months ended June 30, 2020 was $117,000, an increase of $42,000 compared to gross loss of $75,000 for the three months ended June 30, 2019.

 

   
 - 24 - 

 

Research and Development Expenses

 

Research and development expenses for the three months ended June 30, 2020, were $115,000, an increase of $61,000, or 113%, compared to $54,000 for the three months ended June 30, 2019. The increase was primarily due to an increase in payroll expenses, as a result of an increase in share - based compensation expenses (see note 4 to our interim condensed consolidated financial statements as of June 30, 2020) and hiring additional employees.

 

Sales and Marketing Expenses

 

Sales and marketing expenses for the three months ended June 30, 2020, were $136,000, an increase of $93,000, or 216%, compared to $43,000 for the three months ended June 30, 2019. The increase was primarily due to an increase in marketing activities.

 

General and Administrative Expenses

 

General and Administrative expenses for the three months ended June 30, 2020, were $568,000, an increase of $392,000, or 223%, compared to $176,000 for the three months ended June 30, 2019. The increase was primarily due to an increase in payroll expenses, as a result of an increase in share - based compensation expenses (see note 4 to our interim condensed consolidated financial statements as of June 30, 2020) and hiring additional employees and an increase in professional services. The increase in professional services resulted from the incorporation of the Subsidiary as an independent company and in connection with the execution of that certain securities exchange agreement involving the Subsidiary.

 

Operating loss

 

We incurred an operating loss of $936,000 for the three months ended June 30, 2020, an increase of $588,000, or 169%, compared to operating loss of $348,000 for the three months ended June 30, 2019. The increase in operating loss was due to $42,000 increase in gross loss, $61,000 increase in research and development expenses, $93,000 increase in sales and marketing expenses and $392,000 increase in administrative and general expenses.

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

The Company has financed its operations primarily through Medigus, private placement transactions for the issuance of common stock and warrants, and sales to customers.

 

Cash Flows

 

The following table sets forth the significant sources and uses of cash for the periods set forth below (in dollars):

 

   2020   2019 
Cash used in Operating Activity   (1,140,000)   (385,000)
Cash used in Investing Activity   (36,000)   - 
Cash provided by Financing Activity   1,949,000    377,000 
Loss from exchange differences on cash equivalents   (12,000)   - 

 

Operating Activities

 

For the three months ended June 30, 2020, net cash flows used in operating activities was $1,140,000, compared to net cash flows used in operating activities of $385,000 for the three months ended June 30, 2019, an increase of $755,000. The change was mainly due to an increase in net loss, an increase in inventory and an increase in other accrued expenses, which was partially offset by an increase in stock-based compensation.

 

   
 - 25 - 

 

Investing Activities

 

For the three months ended June 30, 2020, net cash flows used in investing activities was $36,000 as compared to $0 for the same period of 2019. The change was due to the purchase of property and equipment during the three months ended June 30, 2020.

 

Financing Activities

 

For the three months ended June 30, 2020, net cash flows provided by financing activities was $1,949,000, compared to net cash flows provided by financing activities of $377,000 for three months ended June 30, 2019.

 

Net cash provided by financing activities in the three months ended June 30, 2020 consisted of proceeds from the issuance of shares and warrant. Net cash provided by financing activities in the three months ended June 30, 2019 was generated from the transfer of funds from Medigus.

 

Loss from exchange differences on cash equivalents

 

During the three months ended June 30, 2020, the Subsidiary generated loss from exchange differences on cash equivalents of $12,000. This loss represents a change in the Company’s cash and cash equivalents as a result of the change in the dollar exchange rate against the NIS during the three months ended June 30, 2020.

 

Future Funding Requirements

 

The Company believes that it will require additional financing in order to provide the capital it needs to achieve its growth targets.

 

Off-Balance Sheet Arrangements

 

The Subsidiary leases its headquarters in Omer, Israel, with a total of approximately 807 gross square meters. In January 2020, ScoutCam extended the agreement through the end of 2020. The rental payments are linked to the Israeli CPI.

 

   
 - 26 - 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

As a smaller reporting company, we are not required to provide the information requested by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2020. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. As a result of the material weakness in our internal control over financial reporting described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of June 30, 2020.

 

In connection with the audit of our 2019 annual consolidated financial statements, we identified a material weakness in our internal control over financial reporting related to the complexities involving the accounting for our reverse recapitalization transaction. The cause of this material weakness was due to the complex accounting related to the reverse recapitalization transaction, which required additional qualified accounting personnel with an appropriate level of experience, and additional controls in the period-end financial reporting process commensurate with the complexity of the matter. A material weakness is defined as a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected and corrected on a timely basis. The material weakness did not result in any identified misstatements to the financial statements, and there were no changes to previously released financial results. In light of the material weakness, we performed additional analyses and other post-closing procedures and hired an additional accounting personnel to ensure our consolidated financial statements are prepared in accordance with U.S. GAAP. Accordingly, our CEO and CFO have certified that, based on their knowledge, the consolidated financial statements, and other financial information included in this Form 10-Q, fairly present in all material respects our financial condition, results of operations and cash flows as of, and for, the periods presented in this Form 10-Q.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Remediation Efforts to Address Material Weakness

 

We began remediation efforts in the second quarter of 2020 for our accounting of non-routine complex transactions control by hiring additional personnel for our finance team. We continue to evaluate our internal and external technical accounting resources to ensure they are appropriate for us and our needs. Additionally, there is a renewed emphasis on our process going forward for initial identification of potential contracts and transactions that may be non-routine and complex during a reporting period, and then conducting the necessary procedures with the full internal accounting team and external consultants to review and research the proper guidance and approach toward the accounting, and documenting as such in a white paper or memo as needed.

 

We believe these measures, and others that may be implemented, will remediate the material weakness in internal control over financial reporting described above.

 

   
 - 27 - 

 

The material weakness will not be considered formally remediated until the control has operated effectively for a sufficient period of time, and after management has concluded, through testing, that the control is operating effectively.

 

Changes in Internal Control over Financial Reporting

 

Other than the changes intended to remediate the material weakness noted above, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended June 30, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II- OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

Not applicable.

 

ITEM 1A. RISK FACTORS.

 

Our business faces many risks, a number of which are described under the caption “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (the “2019 Annual Report”). Other than as set forth below, there have been no material changes from the risk factors previously disclosed in our 2019 Annual Report. The risks described in the 2019 Annual Report and below may not be the only risks we face. Other risks of which we are not yet aware, or that we currently believe are not material, may also materially and adversely impact our business operations or financial results. If any of the events or circumstances described in the risk factors contained in the 2019 Annual Report or described below occurs, our business, financial condition or results of operations could be adversely impacted and the value of an investment in our securities could decline. Investors and prospective investors should consider the risks described in the 2019 Annual Report and below, and the information contained under the caption “Forward-Looking Statements” and elsewhere in this Quarterly Report on Form 10-Q before deciding whether to invest in our securities.

 

The COVID-19 pandemic has adversely affected our business and operations, and the continued outbreak of the pandemic may cause further material and adverse harm to our business and operations.

 

The recent outbreak of COVID-19, which originated in Wuhan, China in late 2019, has since spread to multiple countries, including the United States and Israel. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. While COVID-19 is still spreading and the final implications of the pandemic are difficult to estimate at this stage, it is clear that it has affected the lives of a large portion of the global population. At this time, the pandemic has caused states of emergency to be declared in various countries, travel restrictions imposed globally, quarantines established in certain jurisdictions and various institutions and companies being closed. We are actively monitoring the pandemic and we are taking necessary measures to respond to the situation in cooperation with the various stakeholders.

 

Based on guidelines instituted by the Israeli government, employers (including us) are required to allow employees to work remotely. In that regard, and in compliance with all applicable Israeli rules and guidelines, our offices have remained open since the middle of March 2020, but certain of our essential employees worked, and continue to work, remotely. Accordingly, Israeli containment measures have caused a number of disruptions to our business operations, including, but not limited to, the inability of our employees to access our facilities in a normal fashion.

 

   
 - 28 - 

 

Additionally, COVID-19 may also result in the inability of our manufacturers to deliver components or finished products on a timely basis, and may also result in the inability of our suppliers to deliver the parts required by our manufacturers to complete manufacturing of components or finished products. The extent to which COVID-19 will impact our operations moving forward remains uncertain. A number of factors will determine the trajectory of such impact, including the duration and severity of the outbreak, the possibility of a “second wave”, and the actions that may be required to contain and/or treat COVID-19. In particular, the continued spread of COVID-19 globally could adversely impact our operations and workforce, including our research and clinical trials and its ability to raise capital, which in turn could have an adverse impact on our business, financial condition and results of operation.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURE

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS.

 

(a) The following documents are filed as exhibits to this Quarterly Report or incorporated by reference herein.

 

Exhibit

Number

   Description
10.1   Securities Purchase Agreement, dated May 18, 2020, by and between ScoutCam Inc. and M. Arkin (1999) Ltd. (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on May 19, 2020)
     
10.2   Registration Rights Agreement, dated May 18, 2020, by and between ScoutCam Inc. and M. Arkin (1999) Ltd. (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed with the SEC on May 19, 2020)
     
10.3   Voting Agreement, dated May 18, 2020, by and among ScoutCam Inc. Medigus Ltd. and M. Arkin (1999) Ltd. (incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed with the SEC on May 19, 2020)
     
10.4   Letter Agreement, dated May 18, 2020, by and among ScoutCam Inc., ScoutCam Ltd., Medigus Ltd. and M. Arkin (1999) Ltd. (incorporated by reference to Exhibit 10.4 to our Current Report on Form 8-K filed with the SEC on May 19, 2020)
     
10.5   Warrant A, by and between ScoutCam Inc. and M. Arkin (1999) Ltd. (incorporated by reference to Exhibit 10.5 to our Current Report on Form 8-K filed with the SEC on May 19, 2020)
     
10.6   Warrant B, by and between ScoutCam Inc. and M. Arkin (1999) Ltd. (incorporated by reference to Exhibit 10.6 to our Current Report on Form 8-K filed with the SEC on May 19, 2020)
     
10.7   Side Letter Agreement, by and between ScoutCam Inc. and Medigus Ltd., dated June 23, 2020 (incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on June 24, 2020)
     
10.8   Form of Warrant A by and between ScoutCam Inc. and Medigus Ltd. (incorporated by reference to Exhibit 10.2 to our Current Report on Form 8-K filed with the SEC on June 24, 2020)
     
10.9   Form of Warrant A by and between ScoutCam Inc. and Medigus Ltd. (incorporated by reference to Exhibit 10.3 to our Current Report on Form 8-K filed with the SEC on June 24, 2020)
     
31.1*   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act
     
31.2*   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act
     
32.1**   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2**   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   XBRL Instance Document
     
101.INS   XBRL Taxonomy Extension Schema Document
     
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document
     
*   Filed herewith.
     
**   Furnished herewith.

 

   
 - 29 - 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 12, 2020 SCOUTCAM INC.
     
  By: /s/ Yaron Silberman
  Name: Yaron Silberman
  Title: Chief Executive Officer
    ScoutCam Inc.
     
  By: /s/ Tanya Yosef
  Name: Tanya Yosef
  Title: Chief Financial Officer
    ScoutCam Inc.

 

   

 

 EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Yaron Silberman, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2020 of ScoutCam Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the quarter end covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the quarter end presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the quarter end in which this report is being prepared;
   
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the quarter end covered by this report based on such evaluation; and
   
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 12, 2020  
   
/s/ Yaron Silberman  
Yaron Silberman  
Chief Executive Officer  

 

   
 EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION PURSUANT TO

RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Tanya Yosef, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2020, of ScoutCam Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the quarter end covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the quarter end presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the quarter end in which this report is being prepared;
   
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the quarter end covered by this report based on such evaluation; and
   
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
   
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 12, 2020  
   
/s/ Tanya Yosef  
Tanya Yosef  
Chief Financial Officer  

 

   
 EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of ScoutCam Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Yaron Silberman, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Yaron Silberman  
Yaron Silberman  
Chief Executive Officer  
ScoutCam Inc.  
August 12, 2020  

 

   
 EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of ScoutCam Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tanya Yosef, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Tanya Yosef  
Tanya Yosef  
Chief Financial Officer  
ScoutCam Inc.  
August 12, 2020  

 

   
 EX-101.INS 6 sctc-20200630.xml XBRL INSTANCE FILE 0001577445 2020-01-01 2020-06-30 0001577445 2019-12-31 0001577445 2019-03-31 0001577445 us-gaap:CommonStockMember 2019-06-30 0001577445 us-gaap:CommonStockMember 2019-12-31 0001577445 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001577445 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001577445 us-gaap:RetainedEarningsMember 2019-06-30 0001577445 us-gaap:RetainedEarningsMember 2019-12-31 0001577445 2018-12-31 0001577445 us-gaap:CommonStockMember 2018-12-31 0001577445 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001577445 us-gaap:RetainedEarningsMember 2018-12-31 0001577445 2019-01-01 2019-06-30 0001577445 SCTC:SecuritiesExchangeAgreementMember SCTC:ScoutCamLtdMember 2019-09-16 0001577445 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001577445 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001577445 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001577445 2019-04-01 2019-06-30 0001577445 2019-06-30 0001577445 SCTC:ParentCompanyDeficitMember 2018-12-31 0001577445 SCTC:MedigusLtdMember 2019-03-31 0001577445 SCTC:SecuritiesExchangeAgreementMember SCTC:ScoutCamLtdMember 2019-09-15 2019-09-16 0001577445 SCTC:EachWarrantAMember 2020-06-30 0001577445 SCTC:EachWarrantBMember 2020-06-30 0001577445 SCTC:MedigusLtdMember SCTC:IntercompanyAgreementMember 2019-05-29 2019-05-30 0001577445 2019-12-01 2019-12-31 0001577445 SCTC:WarrantAMember 2020-03-03 0001577445 SCTC:WarrantBMember 2020-03-03 0001577445 SCTC:ConsultantMember 2020-01-01 2020-06-30 0001577445 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001577445 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0001577445 us-gaap:CommonStockMember 2020-06-30 0001577445 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0001577445 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0001577445 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001577445 SCTC:ParentCompanyDeficitMember 2019-01-01 2019-06-30 0001577445 SCTC:ParentCompanyDeficitMember 2019-06-30 0001577445 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0001577445 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0001577445 us-gaap:RetainedEarningsMember 2020-06-30 0001577445 2020-06-30 0001577445 us-gaap:ProductMember 2020-01-01 2020-06-30 0001577445 us-gaap:ProductMember 2019-01-01 2019-06-30 0001577445 us-gaap:ServiceMember 2020-01-01 2020-06-30 0001577445 us-gaap:ServiceMember 2019-01-01 2019-06-30 0001577445 SCTC:LeaseAgreementMember 2020-01-01 2020-06-30 0001577445 us-gaap:WarrantMember 2020-03-02 2020-03-03 0001577445 us-gaap:WarrantMember 2020-03-03 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember SCTC:EmployeesConsultantsDirectorsAndOtherServiceProvidersMember 2020-02-01 2020-02-29 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember SCTC:BoardOfDirectorsMember 2020-03-14 2020-03-15 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember 2020-02-11 2020-02-12 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember 2020-02-12 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember 2020-03-14 2020-03-15 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember 2020-03-15 0001577445 SCTC:ResearchAndDevelopmentMember 2020-01-01 2020-06-30 0001577445 SCTC:GeneralAndAdministrativeMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantAMember 2020-06-30 0001577445 SCTC:WarrantBMember 2020-06-30 0001577445 SCTC:WarrantAOneMember 2020-06-30 0001577445 SCTC:WarrantBOneMember 2020-06-30 0001577445 us-gaap:WarrantMember 2020-06-30 0001577445 SCTC:RelatedPartiesMember 2020-01-01 2020-06-30 0001577445 SCTC:RelatedPartiesMember 2019-01-01 2019-06-30 0001577445 SCTC:WarrantAMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantBMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantAOneMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantBOneMember 2020-01-01 2020-06-30 0001577445 SCTC:MedigusLtdMember 2013-03-22 0001577445 SCTC:LeaseAgreementMember 2020-01-01 2020-01-31 0001577445 us-gaap:ProductMember 2020-04-01 2020-06-30 0001577445 us-gaap:ServiceMember 2020-04-01 2020-06-30 0001577445 2020-04-01 2020-06-30 0001577445 us-gaap:ProductMember 2019-04-01 2019-06-30 0001577445 us-gaap:ServiceMember 2019-04-01 2019-06-30 0001577445 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001577445 us-gaap:CommonStockMember 2020-03-31 0001577445 us-gaap:CommonStockMember 2019-03-31 0001577445 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001577445 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001577445 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001577445 SCTC:ParentCompanyDeficitMember 2019-04-01 2019-06-30 0001577445 SCTC:ParentCompanyDeficitMember 2019-03-31 0001577445 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001577445 us-gaap:RetainedEarningsMember 2020-03-31 0001577445 us-gaap:RetainedEarningsMember 2019-03-31 0001577445 2020-03-31 0001577445 us-gaap:WarrantMember 2020-05-17 2020-05-18 0001577445 us-gaap:WarrantMember 2020-05-18 0001577445 SCTC:EachWarrantAMember 2020-05-18 0001577445 SCTC:EachWarrantBMember 2020-05-18 0001577445 SCTC:LetterAgreementMember SCTC:MedigusLtdMember 2020-06-23 0001577445 SCTC:LetterAgreementMember SCTC:MedigusLtdMember us-gaap:CommonStockMember 2020-06-21 2020-06-23 0001577445 SCTC:LetterAgreementMember SCTC:MedigusLtdMember us-gaap:WarrantMember 2020-06-23 0001577445 SCTC:LetterAgreementMember SCTC:MedigusLtdMember SCTC:WarrantOneMember 2020-06-23 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember SCTC:BoardOfDirectorsMember 2020-06-21 2020-06-22 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember 2020-06-21 2020-06-22 0001577445 SCTC:TwoThousandAndTwentyShareIncentivePlanMember 2020-06-22 0001577445 SCTC:WarrantATwoMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantBTwoMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantATwoMember 2020-06-30 0001577445 SCTC:WarrantBTwoMember 2020-06-30 0001577445 SCTC:WarrantAThreeMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantBThreeMember 2020-01-01 2020-06-30 0001577445 SCTC:WarrantAThreeMember 2020-06-30 0001577445 SCTC:WarrantBThreeMember 2020-06-30 0001577445 SCTC:EachWarrantAMember 2020-06-23 0001577445 SCTC:EachWarrantBMember 2020-06-23 0001577445 SCTC:MedigusLtdMember SCTC:AmendedAndRestatedIntercompanyServicesAgreementMember 2020-04-19 2020-04-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 10-Q false 2020-06-30 --12-31 ScoutCam Inc. Yes Non-accelerated Filer true false 2020 Q2 Yes false 0.001 0.001 0.001 0.001 0.001 0.001 0.001 75000000 75000000 26884921 1000000 33764128 1000000 26884921 33764128 74000 144000 120000 74000 59000 85000 5000 34000 34000 35000 85000 281000 304000 195000 281000 219000 85000 5000 151000 151000 110000 85000 -207000 -160000 -75000 -117000 370000 141000 54000 115000 188000 84000 43000 136000 1680000 292000 176000 568000 -2445000 -677000 -348000 -936000 -0.08 -0.04 -0.02 -0.03 29185 16131 16131 30880 27000 1000 16000 837000 120000 717000 155000 -14000 -19000 25000 4000 -73000 14000 14000 302000 309000 91000 177000 254000 87000 116000 201000 133000 87000 105000 128000 170000 5000 5000 126000 36000 88000 80000 60000 111000 102000 26000 95000 -356000 17000 34000 -155000 -2277000 -899000 -385000 -1140000 -221000 -36000 514000 377000 467000 2777000 981000 377000 1949000 84000 -12000 NV 2013-03-22 1.00 0.595 0.893 0.595 0.893 0.595 0.893 0.595 0.893 0.595 0.893 0.595 0.893 0.595 0.893 0.595 0.893 0.595 0.893 P12M P18M P12M P18M P18M P24M P12M P18M 24000 20000 316000 647000 560000 572000 0.29 0.29 0.29 3413312 979754 2066116 0.968 0.968 0.968 2 1 1 1 1 1 1 1 0.001 1 393736 787471 1 1 3300000 948000 2000000 2000000 250000 900000 23000 6000 363000 82000 -8000 761000 2522000 157000 16000 27000 661000 4135000 -502000 -1640000 -118000 16000 -16000 175000 -118000 34000 8238000 -4023000 4249000 29000 16000 5743000 281000 -3053000 -140000 2719000 16131000 26885000 16131000 33764000 28845000 16131000 514000 514000 -2383000 -691000 -362000 -362000 -189000 -2383000 -502000 -970000 -970000 207000 -207000 467000 377000 377000 467000 871000 3000 3000 3000 871000 3000 170000 170000 6489172 5228007 576888 4367515 576888 3617545 1544769 84000 -12000 221000 36000 81000 2858000 1949000 2858000 6000 1949000 4000 1945000 0.03 0.29 6489172 0.29 0.29 0.29 0.4391 P7Y 0.0125 2020-12-30 2021-06-30 2021-03-03 2021-09-03 2021-11-18 2022-05-18 2021-06-23 2021-12-23 3413317 6826623 979754 1959504 20558753 2066116 4132232 393736 787471 2019-12-30 2019-12-30 2020-03-03 2020-03-03 2020-05-18 2020-05-18 2020-06-23 2020-06-23 33764128 0001577445 54000 31000 0.10 0.475 909000 1900000 The Company expects to recognize during the next 12 months. 41000 4757000 6009000 439000 661000 327000 314000 53000 94000 59000 253000 4318000 5348000 78000 332000 73000 143000 900000 1239000 22000 26000 3245000 3608000 4757000 6009000 -1640000 -4023000 27000 34000 2235000 1760000 325000 348000 296000 297000 29000 51000 1910000 1412000 552000 196000 297000 333000 24000 43000 502000 672000 500000 35000 168000 6092000 4132000 787000 787000 381000 1000 380000 381000 1000 380000 On September 16, 2019, Intellisense entered into a Securities Exchange Agreement (the "Exchange Agreement"), with Medigus, pursuant to which Medigus assigned, transferred and delivered 100% of its holdings in ScoutCam to Intellisense, in exchange for consideration consisting of shares of Intellisense's common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the closing of the Exchange Agreement (the "Closing"). The Closing occurred on December 30, 2019 (the "Closing Date"). In January 2020, the Subsidiary entered into a lease agreement for office space in Omer, Israel. The agreement is for 11 months beginning on February 1, 2020. Monthly lease payments under the agreement are approximately $6 thousand. Lease expenses recorded in the interim consolidated statements of operations were $31 thousand for the six months ended June 30, 2020. P1Y10M25D 31000 23000 106000 12000 94000 The agreed upon services provided under the Intercompany Agreement included: (1) lease of office space and clean room based on actual space utilized by the Subsidiary and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (4) external accountant services at a price of USD 6,000 per annum; (5) directors and officers insurance at a sum of 1/3 of Parent company cost; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (8) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense The agreed upon services provided under the amended and restated Intercompany Agreement included: 1) lease of office space based on actual space utilized by the Parent Company and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (5) directors and officers insurance the Parent Company shall pay $150,000 of the annual premium.; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (7) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense 8000 0.484 381136000 787471 3300000 1203237 3245000 90000 82000 3608000 2847000 381000 381000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 &#8211; BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>A.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Unaudited Interim Financial Statements</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt"><b>B.</b></font></td> <td><font style="font-size: 10pt"><b>Principles of Consolidation</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt"><b>C. </b></font></td> <td><font style="font-size: 10pt"><b>Use of estimates</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt"><b>D.</b></font></td> <td><font style="font-size: 10pt"><b>Significant Accounting Policies</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt"><b>E.</b></font></td> <td><font style="font-size: 10pt"><b>Recently Adopted Accounting Pronouncement</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -14.15pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The significant accounting policies followed in the preparation of these unaudited interim consolidated financial statements are identical to those applied in the preparation of the latest annual audited financial statements with the exception of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In June 2016, the FASB issued ASU 2016-13 &#8220;Financial Instruments &#8211; Credit Losses&#8221; to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. The ASU replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. The Company adopted this ASU on January 1, 2020. There was not a material impact on the interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In August 2018, the FASB issued ASU 2018-13, &#8220;Changes to Disclosure Requirements for Fair Value Measurements,&#8221; which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements and is effective for the Company beginning on January 1, 2020. This standard did not have a material effect on the Company&#8217;s interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In November 2018, the FASB issued ASU 2018-18 &#8211; &#8220;Collaborative Arrangements (Topic 808),&#8221; which clarifies the interaction between Topic 808 and Topic 606, Revenue from Contracts with Customers. The Company adopted this standard in the first quarter of fiscal year 2020. This standard did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-indent: -14.15pt"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px"><font style="font-size: 10pt"><b>F.</b></font></td> <td><font style="font-size: 10pt"><b>Recent Accounting Pronouncements</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -14.15pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In December 2019, the FASB issued ASU No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. The Company does not expect that the adoption of this standard will have a significant impact on the consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 &#8211; REVENUES:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Contract liabilities:&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company&#8217;s contract liabilities as of June 30, 2020 and December 31, 2019 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>USD in thousands</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Contract liabilities</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right"><font style="font-size: 10pt">672</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right"><font style="font-size: 10pt">502</font></td> <td style="width: 1%; padding-bottom: 2.5pt">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Contract liabilities include advance payments, which are primarily related to advanced billings for development services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><u>Remaining Performance Obligations</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Remaining Performance Obligations (&#8220;RPO&#8221;) represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of June 30, 2020, the total RPO amounted to $900 thousand, which the Company expects to recognize during the next 12 months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"><b>NOTE 6 &#8211; INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Composed as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.6pt; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>USD in thousands</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Raw materials and supplies</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">24</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Work in progress</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">647</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">316</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Finished goods</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">572</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">560</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,239</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">900</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">During the period ended June 30, 2020, no impairment occurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"><b>NOTE 7 &#8211; LOSS PER SHARE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Basic loss per share is computed by dividing net loss attributable to ordinary shareholders of the Company, by the weighted average number of ordinary shares as described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In computing the Company&#8217;s diluted loss per share, the numerator used in the basic loss per share computation is adjusted for the dilutive effect, if any, of the Company&#8217;s potential shares of common stock. The denominator for diluted loss per share is a computation of the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The loss per share information in these consolidated financial statements is reflected and calculated as if the Company had existed since January 1, 2019. Accordingly, loss per share for all periods was calculated based on the number of shares retroactively adjusted for the exchange ratio determined in the reverse recapitalization.</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>A.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Unaudited Interim Financial Statements</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>B.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Principles of Consolidation</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 35.45pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>C. </b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Use of estimates</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>D.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Significant Accounting Policies</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>E.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Recently Adopted Accounting Pronouncement</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -14.15pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The significant accounting policies followed in the preparation of these unaudited interim consolidated financial statements are identical to those applied in the preparation of the latest annual audited financial statements with the exception of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In June 2016, the FASB issued ASU 2016-13 &#8220;Financial Instruments &#8211; Credit Losses&#8221; to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. The ASU replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. The Company adopted this ASU on January 1, 2020. There was not a material impact on the interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In August 2018, the FASB issued ASU 2018-13, &#8220;Changes to Disclosure Requirements for Fair Value Measurements,&#8221; which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements and is effective for the Company beginning on January 1, 2020. This standard did not have a material effect on the Company&#8217;s interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In November 2018, the FASB issued ASU 2018-18 &#8211; &#8220;Collaborative Arrangements (Topic 808),&#8221; which clarifies the interaction between Topic 808 and Topic 606, Revenue from Contracts with Customers. The Company adopted this standard in the first quarter of fiscal year 2020. This standard did not have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 48px">&#160;</td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px"><font style="font-size: 10pt"><b>F.</b></font></td> <td style="font: 12pt Times New Roman, Times, Serif"><font style="font-size: 10pt"><b>Recent Accounting Pronouncements</b></font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify; text-indent: -14.15pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In December 2019, the FASB issued ASU No. 2019-12, &#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. The Company does not expect that the adoption of this standard will have a significant impact on the consolidated financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">Supplemental cash flow information related to operating leases was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>USD in thousands</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 73%"><font style="font-size: 10pt">Cash payments for operating leases</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 24%; text-align: right"><font style="font-size: 10pt">23</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Cash payments for short-term lease</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">31</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total lease expenses</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">54</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">Future lease payments under operating leases as of June 30, 2020 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Operating leases</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>USD in thousands</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 73%"><font style="font-size: 10pt">Remainder of 2020</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 24%; text-align: right"><font style="font-size: 10pt">23</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">45</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">38</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Total future lease payments</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">106</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less imputed interest</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total lease liability balance</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">94</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The following table summarizes stock option activity for the six months ended June 30, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the<br /> Six months ended<br /> June 30, 2020</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Amount of options</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted average exercise price</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>$</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Outstanding at beginning of period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Granted</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font-size: 10pt">6,489,172</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font-size: 10pt">0.29</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at end of period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,489,172</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.29</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Vested at end of period</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,203,237</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.29</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Composed as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.6pt; text-align: justify; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>USD in thousands</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Raw materials and supplies</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">24</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Work in progress</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">647</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">316</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Finished goods</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">572</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">560</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,239</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">900</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> 4135000 8238000 62000 -14000 -14000 -34000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Company&#8217;s contract liabilities as of June 30, 2020 and December 31, 2019 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>USD in thousands</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Contract liabilities</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right"><font style="font-size: 10pt">672</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 1%">&#160;</td> <td style="border-bottom: black 2.25pt double; width: 16%; text-align: right"><font style="font-size: 10pt">502</font></td> <td style="width: 1%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As of June 30, 2020, the Company had the following outstanding warrants to purchase Common Stock as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrant</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Issuance Date</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Expiration Date</b></font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price Per Share ($)</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of Shares of Common Stock Underlying Warrants</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 24%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant A</font></td> <td style="width: 3%">&#160;</td> <td style="width: 18%"><font style="font: 10pt Times New Roman, Times, Serif">December 30, 2019</font></td> <td style="width: 2%">&#160;</td> <td style="width: 17%"><font style="font: 10pt Times New Roman, Times, Serif">December 30, 2020</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.595</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,413,317</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">December 30, 2019</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,826,623</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant A</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">March 3, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">March 3, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">979,754</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">March 3, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">September 3, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,959,504</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-family: Times New Roman, Times, Serif">Warrant A</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">May 18, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">November 18, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">0.595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,066,116</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font-family: Times New Roman, Times, Serif">May 18 2020</font></td> <td>&#160;</td> <td><font style="font-family: Times New Roman, Times, Serif">May 18, 2022</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,132,232</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant A</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June&#160;23,&#160;2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June&#160;23,&#160;2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">393,736</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June&#160;23,2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">December&#160;23,&#160;2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">787,471</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>20,558,753</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"><b>NOTE 8 &#8211; RELATED PARTIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On May 30, 2019, the Subsidiary entered into an intercompany agreement with Medigus (the &#8220;Intercompany Agreement&#8221;) according to which the Subsidiary agreed to hire and retain certain services from Medigus. The agreed upon services provided under the Intercompany Agreement included: (1) lease of office space and clean room based on actual space utilized by the Subsidiary and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (4) external accountant services at a price of USD 6,000 per annum; (5) directors and officers insurance at a sum of 1/3 of Parent company cost; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (8) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In addition, the Subsidiary&#8217;s employees provide support services to Medigus.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On April 20, 2020, the Subsidiary entered into an amended and restated intercompany services agreement with Medigus. The agreed upon services provided under the amended and restated Intercompany Agreement included:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">1) lease of office space based on actual space utilized by the Parent Company and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (5) directors and officers insurance the Parent Company shall pay $150,000 of the annual premium.; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (7) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Balances with related parties</b>:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December&#160;31,&#160;2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Parent Company</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 18%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">143</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 18%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">73</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Loan from Parent Company (see note 4(d))</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Transactions with related parties:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Six months ended June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenues</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cost of revenues</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Interest payments</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Transactions with related parties:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Six months ended June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenues</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cost of revenues</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Interest payments</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Balances with related parties</b>:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>December&#160;31,&#160;2019</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: justify">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Parent Company</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 18%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">143</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 18%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">73</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Loan from Parent Company (see note 4(d))</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">500</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt"><b>NOTE 4 &#8211; EQUITY:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b>Private placement:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 48px; text-align: justify">&#160;</td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">a.</font></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In December 2019, the Company allotted in a private issuance, a total of 3,413,312 units at a purchase price of USD $0.968 per unit. Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below). The immediate proceeds (gross) from the issuance of the units amounted to approximately USD 3.3 million.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 month period following the allotment. Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 month period following the allotment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In addition, Shrem Zilberman Group Ltd. (the &#8220;Consultant&#8221;) will be entitled to receive the amount representing 3% of any exercise price of each Warrant A or Warrant B that may be exercised in the future. In the event the total proceeds received as a result of exercise of Warrants will be less than $2 million at the time of their expiration, the Consultant will be required to invest $250,000 in the Company in return for shares of common stock of Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify">&#160;</td> <td style="width: 24px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">b.</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On March 3, 2020, the Company allotted in a private issuance a total of 979,754 units at a purchase price of USD $0.968 per unit.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 month period following the allotment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 month period following the allotment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The immediate proceeds (gross) from the issuance of all securities offered amounted to approximately USD 948 thousands. After deducting closing costs and fees, the Company received proceeds of approximately USD 909 thousand, net of issuance expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">c.</font></td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On May 18, 2020, the Company allotted in a private issuance a total of 2,066,116 units at a purchase price of USD $0.968 per unit.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 18 month period following the allotment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 24 month period following the allotment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The immediate proceeds (gross) from the issuance of all securities offered amounted to approximately USD 2 million. After deducting closing costs and fees, the Company received proceeds of approximately USD 1.9 million, net of issuance expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">d.</font></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 23, 2020, (the &#8220;Conversion Date&#8221;) the Company entered into and consummated a Side Letter Agreement with Medigus, whereby the parties agreed to convert, at a conversion price of $0.484, an outstanding line of credit previously extended by Medigus to the Subsidiary, which as of the Conversion Date was $381,136, into (a) 787,471 shares of the Company&#8217;s common stock, (b) warrants to purchase 393,736 shares of common stock with an exercise price of $0.595 (Warrant A), and (c) warrants to purchase 787,471 shares of common stock with an exercise price of $0.893 (Warrant B).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 months period following the allotment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 months period following the allotment.&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -18.55pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">As of June 30, 2020, the Company had the following outstanding warrants to purchase Common Stock as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Warrant</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Issuance Date</b></font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Expiration Date</b></font></td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price Per Share ($)</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of Shares of Common Stock Underlying Warrants</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 22%"><font style="font: 10pt Times New Roman, Times, Serif">Warrant A</font></td> <td style="width: 2%">&#160;</td> <td style="width: 18%"><font style="font: 10pt Times New Roman, Times, Serif">December 30, 2019</font></td> <td style="width: 2%">&#160;</td> <td style="width: 18%"><font style="font: 10pt Times New Roman, Times, Serif">December 30, 2020</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.595</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,413,317</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">December 30, 2019</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June 30, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,826,623</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant A</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">March 3, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">March 3, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">979,754</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">March 3, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">September 3, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,959,504</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-family: Times New Roman, Times, Serif">Warrant A</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">May 18, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">November 18, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-family: Times New Roman, Times, Serif">0.595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,066,116</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font-family: Times New Roman, Times, Serif">May 18 2020</font></td> <td>&#160;</td> <td><font style="font-family: Times New Roman, Times, Serif">May 18, 2022</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4,132,232</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant A</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June 23, 2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June 23, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.595</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">393,736</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Warrant B</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">June 23,2020</font></td> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">December 23, 2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.893</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">787,471</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif"><b>20,558,753</b></font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>Share-based compensation to employees and to directors:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In February 2020, the Company&#8217;s Board of Directors approved the 2020 Share Incentive Plan (the &#8220;Plan&#8221;). The Plan initially included a pool of 5,228,007 shares of common stock for grant to Company employees, consultants, directors, and other service providers. On March 15, 2020, the Company&#8217;s Board of Directors approved an increase to the Company&#8217;s option pool pursuant to the Plan by an additional 576,888 shares of Common Stock. On June 22, 2020, the Company&#8217;s Board of Directors approved an increase to the Company&#8217;s option pool pursuant to the Plan by an additional 3,617,545 shares of Common Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The Plan is designed to enable the Company to grant options to purchase ordinary shares and RSUs under various and different tax regimes including, without limitation: (i) pursuant and subject to Section 102 of the Israeli Tax Ordinance or any provision which may amend or replace it and any regulations, rules, orders or procedures promulgated thereunder and to designate them as either grants made through a trustee or not through a trustee; and (ii) pursuant and subject to Section 3(i) of the Israeli Tax Ordinance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On February 12, 2020, the Company granted 4,367,515 options pursuant to the Plan. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On March 15, 2020, the Company granted 576,888 options pursuant to the Plan to each of the Company&#8217;s then serving directors, excluding Professor Benad Goldwasser. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">On June 22, 2020, the Company granted 1,544,769 options pursuant to the Plan to Company employees, consultants, directors. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value of each option was estimated as of the grant date or reporting period using the Black-Scholes option-pricing model, using the following assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Underlying value of ordinary shares ($)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.475</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price ($)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.29</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility (%)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">43.91</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Term of the options (years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate (%)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The cost of the benefit embodied in the options granted during the six months ended June 30, 2020, based on their fair value as at the grant date, is estimated to be approximately $3.3 million. These amounts will be recognized in statements of operations over the vesting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The following table summarizes stock option activity for the six months ended June 30, 2020:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For the</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Amount of options</b></font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted average exercise price</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>$</b></font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at beginning of period</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 62%"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,489,172</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td> <td style="border-bottom: black 1.5pt solid; width: 16%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.29</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding at end of period</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,489,172</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.29</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Vested at end of period</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,203,237</font></td> <td>&#160;</td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.29</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The following table sets forth the total share-based payment expenses resulting from options granted, included in the statements of operation:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>USD in thousands</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 73%"><font style="font: 10pt Times New Roman, Times, Serif">Research and development</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 24%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">120</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">General and administrative</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">717</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total expenses</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">837</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The following table sets forth the total share-based payment expenses resulting from options granted, included in the statements of operation:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>USD in thousands</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 73%"><font style="font: 10pt Times New Roman, Times, Serif">Research and development</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 24%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">120</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">General and administrative</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">717</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total expenses</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">837</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">The fair value of each option was estimated as of the grant date or reporting period using the Black-Scholes option-pricing model, using the following assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify">&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 82%; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Underlying value of ordinary shares ($)</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.475</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Exercise price ($)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.29</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Expected volatility (%)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">43.91</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Term of the options (years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free interest rate (%)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.25</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 &#8211; LEASES:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: 7.1pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">On January 1, 2019, the Company adopted ASU 2016-02 using the modified retrospective approach for all lease arrangements at the beginning period of adoption. The Subsidiary leases office and vehicles under operating leases. On June 30, 2020, the Company&#8217;s ROU assets and lease liabilities for operating leases totalled $94 thousand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">In January 2020, the Subsidiary entered into a lease agreement for office space in Omer, Israel. The agreement is for 11 months beginning on February 1, 2020. Monthly lease payments under the agreement are approximately $6 thousand. Lease expenses recorded in the interim consolidated statements of operations were $31 thousand for the six months ended June 30, 2020. The Company has elected the short-term lease exception for this lease. As part of this election it will not recognize right-of-use assets and lease liabilities on the balance sheet for this lease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">Supplemental cash flow information related to operating leases was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Six months ended</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>June 30, 2020</b></p></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>USD in thousands</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 73%"><font style="font: 10pt Times New Roman, Times, Serif">Cash payments for operating leases</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 24%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Cash payments for short-term lease</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">31</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total lease expenses</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">54</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 56.7pt; text-align: justify">As of June 30, 2020, the Company&#8217;s operating leases had a weighted average remaining lease term of 1.9 years and a weighted average discount rate of 10%. Future lease payments under operating leases as of June 30, 2020 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Operating leases</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>USD in thousands</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 73%"><font style="font: 10pt Times New Roman, Times, Serif">Remainder of 2020</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 24%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">23</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">45</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">2022</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">38</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total future lease payments</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">106</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font: 10pt Times New Roman, Times, Serif">Less imputed interest</font></td> <td>&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(12</font></td> <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font: 10pt Times New Roman, Times, Serif">Total lease liability balance</font></td> <td>&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">94</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63.8pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 &#8211; GENERAL:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.6pt; text-align: justify; text-indent: -49.6pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%"> <tr style="vertical-align: top"> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 48px; text-align: justify">&#160;</td> <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 24px; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>a</b>.</font></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ScoutCam Inc. (the &#8220;Company&#8221;), formally known as Intellisense Solutions Inc. (&#8220;Intellisense&#8221;), was incorporated under the laws of the State of Nevada on March 22, 2013 under the name Intellisense Solutions Inc. The Company was initially engaged in the business of developing web portals to allow companies and individuals to engage in the purchase and sale of vegetarian food products over the Internet. The Company was unable to execute its original business plan, develop significant operations or achieve commercial sales. Prior to the closing of the Securities Exchange Agreement (as defined below), the Company was a &#8220;shell company&#8221;.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ScoutCam Ltd. (the &#8220;Subsidiary&#8221;, &#8220;ScoutCam&#8221;), was formed in the State of Israel on January 3, 2019 as a wholly-owned subsidiary of Medigus Ltd. (the &#8220;Parent Company&#8221;, &#8220;Medigus&#8221;), an Israeli company traded both on the Nasdaq Capital Market and the Tel Aviv Stock Exchange, and commenced operations on March 1, 2019. Upon incorporation, the Subsidiary issued to Medigus 1,000,000 Ordinary shares with no par value. On March 2019, the Subsidiary issued to Medigus an additional 1,000,000 Ordinary shares with no par value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Subsidiary was incorporated as part of a reorganization of Medigus, which was designed to distinguish the Subsidiary miniaturized imaging business, or the micro ScoutCam&#8482; portfolio, from Medigus&#8217;s other operations and to enable Medigus to form a separate business unit with dedicated resources focused on the promotion of such technology. In December 2019, Medigus and the Subsidiary consummated a certain Amended and Restated Asset Transfer Agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to the Subsidiary.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 16, 2019, Intellisense entered into a Securities Exchange Agreement (the &#8220;Exchange Agreement&#8221;), with Medigus, pursuant to which Medigus assigned, transferred and delivered 100% of its holdings in the Subsidiary to Intellisense, in exchange for consideration consisting of shares of Intellisense&#8217;s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the closing of the Exchange Agreement (the &#8220;Closing&#8221;). The Closing occurred on December 30, 2019 (the &#8220;Closing Date&#8221;). On December 31, 2019, Intellisense changed its name to ScoutCam Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although the transaction resulted in the ScoutCam becoming a wholly owned subsidiary of Intellisense, the transaction constituted a reverse recapitalization since Medigus, the only shareholder of the ScoutCam prior to the Exchange Agreement, was issued a substantial majority of the outstanding capital stock of Intellisense upon consummation of the Exchange Agreement, and also taking into account that prior to the Closing Date, Intellisense was considered as a shell corporation. Accordingly, the Subsidiary is considered the accounting acquirer of the merged company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Subsidiary has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam&#8482; 1.2. These innovative cameras are suitable for both medical and industrial applications. Based on its proprietary technology, The Subsidiary designs and manufactures endoscopy and micro camera systems for partner companies.</p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60.65pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>b.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying comparative consolidated financial statements include the historical accounts of the Subsidiary as a &#8220;Carve-out Business&#8221;, a division of Medigus. Throughout the comparative periods included in these Financial Statements, the Carve-out Business operated as part of Medigus. Separate financial statements have not historically been prepared for the Carve-out Business. These comparative carve-out financial data has been prepared on a standalone basis and is derived from Medigus&#8217;s consolidated financial statements and accounting records. The carve-out comparative financial data reflects the Subsidiary&#8217;s financial position, results of operations, changes in net parent deficit and cash flows in accordance with U.S. GAAP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial position, results of operations, changes in net parent deficit, and cash flows of the Carve-out Business may not be indicative of its results had it been a separate stand-alone entity during the comparative periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The comparative carve-out financial data of the Company includes expenses which were allocated from Medigus for certain functions, including general corporate expenses related to corporate strategy, procurement, Information Technology (&#8220;IT&#8221;), Human Resources (&#8220;HR&#8221;) and legal. These allocation have been made on the basis of direct usage when identifiable, with the remainder allocated on the basis of headcount. Management believes the expense allocation methodology and results are reasonable and consistently applied for all comparative periods presented. However, these allocations may not be indicative of the actual expenses that would have been incurred by an independent company or of the costs to be incurred in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carve-out comparative financial statements include assets and liabilities specifically attributable to the Carve-out Business. Medigus uses a centralized approach for managing cash and financing operations. Accordingly, a substantial portion of the cash balances are transferred to Medigus&#8217; cash management accounts regularly and therefore are not included in the financial statements. Transfers of cash between Carve-out business and Medigus are included within &#8220;Net transfers from Parent company&#8221; on the Statements of Cash Flows and the Statements of changes in shareholder&#8217;s equity (capital deficiency).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As the carve-out comparative financial information has been prepared on a carve-out basis, the amounts reflected in Parent Company deficit in the comparative statement of changes in shareholder&#8217;s equity (capital deficiency) refer to net loss for the period attributed to the Subsidiary in addition to transactions between Medigus and the Subsidiary.</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">c.</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During the six month ended June 30, 2020, the Company incurred a loss of USD 2,383 thousand and negative cash flows from operating activities of approximately USD 2,277 thousand. Based on the projected cash flows, the Company&#8217;s Management is of the opinion that without further fundraising it will not have sufficient resources to enable it to continue its operating activities including the development, manufacturing and marketing of its products within one year after the issuance date of these financial statements. As a result, there is a substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the issuance date of these financial statements.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Management&#8217;s plans include continuing commercialization of the Company&#8217;s products and securing sufficient financing through the sale of additional equity securities, debt or capital inflows from strategic partnerships and other opportunities. There are no assurances however, that the Company will be successful in obtaining the level of financing needed for its operations. If the Company is unsuccessful in commercializing its products and securing sufficient financing, it may need to reduce activities, curtail or even cease operations.</font></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These consolidated financial statements have been prepared assuming the Company will continue as a going concern, which assumes the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policies set out below have, unless otherwise stated, been applied consistently.</p></td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td>&#160;</td> <td><font style="font: 10pt Times New Roman, Times, Serif">d.</font></td> <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The coronavirus (&#8220;COVID-19&#8221;), which was declared in March 2020 by the World Health Organization as a pandemic, has had a significant impact on global markets and the economy of many countries, including countries in which the Company operates. As the ultimate impact on the global economy of the COVID-19 pandemic remains unclear, the Company anticipates that it will have a continuing impact on global economies in the near future. While the COVID-19 pandemic has not materially affected the Company&#8217;s operations as of the date hereof, the extent to which the COVID-19 pandemic shall impact the Company&#8217;s operations will depend on future developments. In particular, the continued spread of COVID-19 globally could materially adversely impact the Company&#8217;s operations and workforce, including its manufacturing activities, product sales, as well as its ability to continue to raise capital. Travel restrictions could materially adversely impact our sales and marketing and research and development efforts.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"></p> 38000 45000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><b>NOTE 9 - SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">In accordance with ASC 855 &#8220;Subsequent Events&#8221; the Company evaluated subsequent events through the date the condensed consolidated financial statements were issued. The Company concluded that no subsequent events have occurred that would require recognition or disclosure in the condensed consolidated financial statements.</p> EX-101.SCH 7 sctc-20200630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Interim Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Interim Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Interim Condensed Conolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Revenues link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Loss Per Share link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Parties link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Revenues (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Related Parties (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - General (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Leases - Schedule of Maturities Lease Liabilities Under Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Equity - Schedule of Stock Warrants Outstanding to Purchase Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Equity - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Equity - Schedule of Stock Options Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Equity - Schedule of Total Share-based Payment Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Revenues (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Revenues - Schedule of Contract Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Inventory (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Inventory - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Related Parties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Related Parties - Schedule of Balances with Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Related Parties - Schedule of Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 sctc-20200630_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 sctc-20200630_def.xml XBRL DEFINITION FILE EX-101.LAB 10 sctc-20200630_lab.xml XBRL LABEL FILE Equity Components [Axis] Ordinary Shares [Member] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Exchange Agreement [Member] Legal Entity [Axis] ScoutCam Ltd., [Member] Parent Company Deficit [Member] Medigus Ltd [Member] Each Warrant A [Member] Each Warrant B [Member] Intercompany Agreement [Member] Warrant A [Member] Warrant B [Member] Title of Individual [Axis] Consultant [Member] Product and Service [Axis] Products [Member] Services [Member] Lease Agreement [Member] Warrant [Member] Plan Name [Axis] 2020 Share Incentive Plan [Member] Employees, Consultants, Directors and Other Service Providers [Member] Board of Directors [Member] Income Statement Location [Axis] Research and Development [Member] General and Administrative [Member] Warrant A One [Member] Warrant B One [Member] Related Parties [Member] Letter Agreement [Member] Warrant One [Member] Warrant A Two [Member] Warrant B Two [Member] Warrant A Three [Member] Warrant B Three [Member] Amended and Restated Intercompany Services Agreement [Member] Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets CURRENT ASSETS: Cash and cash equivalents Accounts receivables Inventory Parent company Other current assets Total current assets NON-CURRENT ASSETS: Property and equipment, net Operating lease right-of-use assets Severance pay asset Total non-current assets TOTAL ASSETS Liabilities and shareholders' equity CURRENT LIABILITIES: Accounts payables Loan from Parent company Contract liabilities Operating lease liabilities - short term Accrued compensation expenses Other accrued expenses Total current liabilities NON-CURRENT LIABILITIES: Operating lease liabilities - long term Liability for severance pay Total non-current liabilities TOTAL LIABILITIES SHAREHOLDERS' EQUITY: Ordinary shares Common stock, $0.001 par value; 75,000,000 shares authorized, 33,764,128 and 26,884,921 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively Additional paid-in capital Accumulated deficit TOTAL SHAREHOLDERS' EQUITY TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Revenues: Revenues Cost of revenues: Cost of revenues Gross Loss Research and development expenses Sales and marketing expenses General and administrative expenses Operating loss Financing income (expenses), net Net Loss Net loss per ordinary share (basic and diluted, USD) Weighted average ordinary shares (basic and diluted, in thousands) Balance Balance, shares Capital contribution from Parent company Consummation of the Carve-out Stock based compensation Net transfer from Parent company Issuance of shares and warrants Issuance of shares and warrants, shares Conversion of a loan from Parent company Conversion of a loan from Parent company, shares Net loss Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operations: Depreciation Other non-cash items Share based compensation Loss (Profit) from exchange differences on cash and cash equivalents CHANGES IN OPERATING ASSET AND LIABILITY ITEMS: Accounts receivable Inventory Parent company Other current assets Accounts payables Contract liabilities Accrued compensation expenses Other accrued expenses Net cash flows used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Net cash flows used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Loan repayment to Parent company Transfer from Parent company Capital Contribution from Parent company Proceeds from issuance of shares and warrants Net cash flows provided by financing activities PROFIT (LOSS) FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS BALANCE OF CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD BALANCE OF CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD Non cash activities - Parent Company loan settled against Parent Company receivable Conversion of a loan from Parent company Organization, Consolidation and Presentation of Financial Statements [Abstract] General Accounting Policies [Abstract] Basis of Presentation and Significant Accounting Policies Leases [Abstract] Leases Equity [Abstract] Equity Revenue from Contract with Customer [Abstract] Revenues Inventory Disclosure [Abstract] Inventory Earnings Per Share [Abstract] Loss Per Share Related Party Transactions [Abstract] Related Parties Subsequent Events [Abstract] Subsequent Events Unaudited Interim Financial Statements Principles of Consolidation Use of Estimates Significant Accounting Policies Recently Adopted Accounting Pronouncement Recent Accounting Pronouncements Schedule of Supplemental Cash Flow Information Related to Operating Leases Schedule of Maturities Lease Liabilities Under Operating Leases Schedule of Stock Warrants Outstanding to Purchase Common Stock Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Stock Options Activity Schedule of Total Share-based Payment Expenses Schedule of Contract Liabilities Schedule of Inventory Schedule of Balances with Related Parties Schedule of Related Party Transactions State country code Date of incorporation Common stock, par value Equity ownership percentage Exchange agreement description Net cash used in operating activities Lease description Monthly lease, payments Lease expenses Weighted average remaining lease term Weighted average discount rate Cash payments for operating leases Cash payments for short-term lease Total lease expenses Remainder of 2020 2021 2022 Total future lease payments Less imputed interest Total lease liability balance Allotted in private issuance Shares issued price per share Number of common stock Common stock par value Proceeds from issuance of common stock Number of warrants Warrants exercise price Warrant term Warrant exercise price percentage Proceeds from exercise of warrant Number of common stock value Proceeds from issuance of shares net of issuance expense Convertible conversion price Conversion Convertible debt Convert conversion Share-based compensation granted shares Stock option, exercise price Share-based compensation vested in period, fair value Warrant, Issuance Date Warrant, Expiration Date Warrant, Exercise Price Per Share Warrant, Number of Shares of Common Stock Underlying Warrants Underlying value of ordinary shares Exercise price Expected volatility Term of the options (years) Risk-free interest rate Options, Outstanding at beginning of period Options, Granted Options, Outstanding at end of period Options, Vested at end of period Weighted average exercise price, Outstanding at beginning of period Weighted average exercise price, Granted Weighted average exercise price, Outstanding at end of period Weighted average exercise price, Vested at end of period Total expenses Remaining performance obligations Revenue remaining performance obligation expected period description Impairment occurred Raw materials and supplies Work in progress Finished goods Inventory net Intercompany agreement description Parent Company Loan from Parent Company (see note 4(d)) Interest payments Consummation of the Carve-out. Capital contribution from Parent company. Amir Uziel, Lavi Krasney, L.I.A. Pure Capital Ltd. Nir Reinhold and Yaad Consulting &amp; Management Services (1995) Ltd [Member] Amir Uziel [Member] Asset Transfer Agreement [Member] Attibute Ltd [Member] Benad Goldwasser [Member] Board of Directors [Member] Book Keeping Services [Member] Canna Patch Ltd [Member] Class A Warrant [Member] Consultant [Member] Consulting agreement [Member] Customer A [Member] Customer B [Member] Customer C [Member] Customer C Parent Company [Member] Customer D Parent Company [Member] Each Warrant A [Member] Each Warrant B [Member] Employees, Consultants, Directors and Other Service Providers [Member] Eventus [Member] Exchange agreement description. Exchange Agreement [Member] Five Investor [Member] Five Investors [Member] Four Investors [Member] Fourteen New Shareholders [Member] Intercompany agreement description. Intercompany Agreement [Member] January 1, 2020 [Member] January 1, 2021 [Member] January 1, 2020 [Member] January 1, 2021 [Member] South Korea [Member] L.I.A. Pure Capital Ltd [Member] Lavi Krasney [Member] Liability for severance pay. May 1, 2019 [Member] May 1, 2019 [Member] Medigus Ltd [Member] Mr. Rafael Ezra [Member] Nir Reinhold [Member] Notes Payable Eight [Member] Notes Payable Eighteen [Member] Notes Payable Eleven [Member] Notes Payable Fifteen [Member] Notes Payable Five [Member] Notes Payable Four [Member] Notes Payable Fourteen [Member] Notes Payable Nine [Member] Notes Payable Nineteen [Member] Notes Payable One [Member] Notes Payable Seven [Member] Notes Payable Seventeen [Member] Notes Payable Six [Member] Notes Payable Sixteen [Member] Notes Payable Ten [Member] Notes Payable Thirteen [Member] Notes Payable Three [Member] Notes Payable Twelve [Member] Notes Payable Twenty [Member] Notes Payable Two [Member] Number of common stock. Oded Gilboa [Member] One Promissory Note [Member] Optima Service Agreement [Member] Optima Service Agreement [Member] Optima Solutions Ltd [Member] Other [Member] Other Shareholder [Member] Parent Company Deficit [Member] Transfer from Parent company. Recapitalization [Member] Research and Option Agreement [Member] ScoutCam Ltd., [Member] Securities Exchange Agreement [Member] Service Agreement [Member] Severance pay asset. Shareholder One [Member] Shrem Zilberman Group Ltd [Member] Net transfer from Parent company. Subscription Receivable [Member] 2020 Share Incentive Plan [Member] Warrant A [Member] Warrant B [Member] Warrant One [Member] Warrant Three [Member] Warrant Two [Member] Yaad Consulting &amp; Management Services (1995) Ltd [Member] Proceeds from issuance of shares and warrants. Issuance of shares and warrants, shares. Issuance of shares and warrants. Unaudited interim financial statements [Policy Text Block] Significant accounting policies [Policy Text Block] Disclosure of accounting policy pertaining to new accounting pronouncement that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact. Schedule of balances with related parties [Table Text Block] Lease Agreement [Member] Warrant exercise price percentage. General and Administrative - Professional Services [Member] Warrant A One [Member] Warrant B One [Member] Related Parties [Member] Warrant, Issuance Date Proceeds from issuance of shares net of issuance expense. Parent Company loan settled against Parent Company receivable. Research and Development [Member] General and Administrative [Member] Conversion of a loan from Parent company. Conversion of a loan from Parent company, shares. Conversion of a loan from Parent company. Interest payments. Letter Agreement [Member] Warrant A Two [Member] Warrant B Two [Member] Warrant A Three [Member] Warrant B Three [Member] Financing income (expenses), net. Amended and Restated Intercompany Services Agreement [Member] Assets, Current Assets, Noncurrent Assets [Default Label] Liabilities, Current Liabilities, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Income (Loss) Shares, Outstanding Other Noncash Income (Expense) Foreign Currency Transaction Gain (Loss), before Tax Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Due from Related Parties, Current Increase (Decrease) in Other Current Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Other Employee-Related Liabilities Increase (Decrease) in Workers' Compensation Liabilities Increase (Decrease) in Other Accrued Liabilities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations ConversionOfLoanFromParentCompany Revenue from Contract with Customer [Text Block] Inventory Disclosure [Text Block] Common Stock, No Par Value Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price EX-101.PRE 11 sctc-20200630_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information
 6 Months Ended
Jun. 30, 2020
shares
Cover [Abstract]  
Entity Registrant Name ScoutCam Inc.
Entity Central Index Key 0001577445
Document Type 10-Q
Document Period End Date Jun. 30, 2020
Amendment Flag false
Current Fiscal Year End Date --12-31
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Small Business Flag true
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 33,764,128
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2020
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS:    
Cash and cash equivalents $ 3,608 $ 3,245
Accounts receivables 26 22
Inventory 1,239 900
Parent company 143 73
Other current assets 332 78
Total current assets 5,348 4,318
NON-CURRENT ASSETS:    
Property and equipment, net 253 59
Operating lease right-of-use assets 94 53
Severance pay asset 314 327
Total non-current assets 661 439
TOTAL ASSETS 6,009 4,757
CURRENT LIABILITIES:    
Accounts payables 168 35
Loan from Parent company 500
Contract liabilities 672 502
Operating lease liabilities - short term 43 24
Accrued compensation expenses 333 297
Other accrued expenses 196 552
Total current liabilities 1,412 1,910
NON-CURRENT LIABILITIES:    
Operating lease liabilities - long term 51 29
Liability for severance pay 297 296
Total non-current liabilities 348 325
TOTAL LIABILITIES 1,760 2,235
SHAREHOLDERS' EQUITY:    
Ordinary shares Common stock, $0.001 par value; 75,000,000 shares authorized, 33,764,128 and 26,884,921 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 34 27
Additional paid-in capital 8,238 4,135
Accumulated deficit (4,023) (1,640)
TOTAL SHAREHOLDERS' EQUITY 4,249 2,522
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 6,009 $ 4,757
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 75,000,000 75,000,000
Common stock, shares issued 33,764,128 26,884,921
Common stock, shares outstanding 33,764,128 26,884,921
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Revenues $ 34 $ 120 $ 74 $ 144
Cost of revenues:        
Cost of revenues 151 195 281 304
Gross Loss (117) (75) (207) (160)
Research and development expenses 115 54 370 141
Sales and marketing expenses 136 43 188 84
General and administrative expenses 568 176 1,680 292
Operating loss (936) (348) (2,445) (677)
Financing income (expenses), net (34) (14) 62 (14)
Net Loss $ (970) $ (362) $ (2,383) $ (691)
Net loss per ordinary share (basic and diluted, USD) $ (0.03) $ (0.02) $ (0.08) $ (0.04)
Weighted average ordinary shares (basic and diluted, in thousands) 30,880 16,131 29,185 16,131
Products [Member]        
Revenues:        
Revenues $ 34 $ 35 $ 74 $ 59
Cost of revenues:        
Cost of revenues 151 110 281 219
Services [Member]        
Revenues:        
Revenues 85 85
Cost of revenues:        
Cost of revenues $ 85 $ 85
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Parent Company Deficit [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 16 $ (16) $ (118) $ (118)
Balance, shares at Dec. 31, 2018 16,131,000        
Capital contribution from Parent company 467 467
Consummation of the Carve-out 207 (207)
Stock based compensation 3 3
Net transfer from Parent company 514 514
Net loss (189) (502) (691)
Balance at Jun. 30, 2019 $ 16 661 (502) 175
Balance, shares at Jun. 30, 2019 16,131,000        
Balance at Mar. 31, 2019 $ 16 281 (140) 157
Balance, shares at Mar. 31, 2019 16,131,000        
Capital contribution from Parent company 377 377
Stock based compensation 3 3
Net loss (362) (362)
Balance at Jun. 30, 2019 $ 16 661 (502) 175
Balance, shares at Jun. 30, 2019 16,131,000        
Balance at Dec. 31, 2019 $ 27 4,135   (1,640) 2,522
Balance, shares at Dec. 31, 2019 26,885,000        
Stock based compensation 871   871
Issuance of shares and warrants $ 6   2,858
Issuance of shares and warrants, shares 6,092,000        
Conversion of a loan from Parent company $ 1 380   381
Conversion of a loan from Parent company, shares 787,000        
Net loss   (2,383) (2,383)
Balance at Jun. 30, 2020 $ 34 8,238   (4,023) 4,249
Balance, shares at Jun. 30, 2020 33,764,000        
Balance at Mar. 31, 2020 $ 29 5,743   (3,053) 2,719
Balance, shares at Mar. 31, 2020 28,845,000        
Stock based compensation 170   170
Issuance of shares and warrants $ 4 1,945   1,949
Issuance of shares and warrants, shares 4,132,000        
Conversion of a loan from Parent company $ 1 380   381
Conversion of a loan from Parent company, shares 787,000        
Net loss   (970) (970)
Balance at Jun. 30, 2020 $ 34 $ 8,238   $ (4,023) $ 4,249
Balance, shares at Jun. 30, 2020 33,764,000        
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Interim Condensed Conolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss $ (970) $ (362) $ (2,383) $ (691)
Adjustments to reconcile net loss to net cash used in operations:        
Depreciation 16 27 1
Other non-cash items (25) 14 19
Share based compensation 155 837
Loss (Profit) from exchange differences on cash and cash equivalents 12 (84)
CHANGES IN OPERATING ASSET AND LIABILITY ITEMS:        
Accounts receivable (14) (14) (4) 73
Inventory (177) (91) (302) (309)
Parent company (95) (26) (111) (102)
Other current assets (201) (116) (254) (87)
Accounts payables 128 105 133 87
Contract liabilities 126 5 170 5
Accrued compensation expenses 60 80 36 88
Other accrued expenses (155) 34 (356) 17
Net cash flows used in operating activities (1,140) (385) (2,277) (899)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of property and equipment (36) (221)
Net cash flows used in investing activities (36) (221)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Loan repayment to Parent company (81)
Transfer from Parent company 377 514
Capital Contribution from Parent company 467
Proceeds from issuance of shares and warrants 1,949 2,858
Net cash flows provided by financing activities 1,949 377 2,777 981
PROFIT (LOSS) FROM EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS (12) 84
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 761 (8) 363 82
BALANCE OF CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD 2,847 90 3,245
BALANCE OF CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD 3,608 82 3,608 82
Non cash activities -        
Parent Company loan settled against Parent Company receivable 41
Conversion of a loan from Parent company $ 381 $ 381
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
General
 6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
General

NOTE 1 – GENERAL:

 

  a.

ScoutCam Inc. (the “Company”), formally known as Intellisense Solutions Inc. (“Intellisense”), was incorporated under the laws of the State of Nevada on March 22, 2013 under the name Intellisense Solutions Inc. The Company was initially engaged in the business of developing web portals to allow companies and individuals to engage in the purchase and sale of vegetarian food products over the Internet. The Company was unable to execute its original business plan, develop significant operations or achieve commercial sales. Prior to the closing of the Securities Exchange Agreement (as defined below), the Company was a “shell company”.

 

ScoutCam Ltd. (the “Subsidiary”, “ScoutCam”), was formed in the State of Israel on January 3, 2019 as a wholly-owned subsidiary of Medigus Ltd. (the “Parent Company”, “Medigus”), an Israeli company traded both on the Nasdaq Capital Market and the Tel Aviv Stock Exchange, and commenced operations on March 1, 2019. Upon incorporation, the Subsidiary issued to Medigus 1,000,000 Ordinary shares with no par value. On March 2019, the Subsidiary issued to Medigus an additional 1,000,000 Ordinary shares with no par value.

 

The Subsidiary was incorporated as part of a reorganization of Medigus, which was designed to distinguish the Subsidiary miniaturized imaging business, or the micro ScoutCam™ portfolio, from Medigus’s other operations and to enable Medigus to form a separate business unit with dedicated resources focused on the promotion of such technology. In December 2019, Medigus and the Subsidiary consummated a certain Amended and Restated Asset Transfer Agreement, under which Medigus transferred and assigned certain assets and intellectual property rights related to its miniaturized imaging business to the Subsidiary.

 

On September 16, 2019, Intellisense entered into a Securities Exchange Agreement (the “Exchange Agreement”), with Medigus, pursuant to which Medigus assigned, transferred and delivered 100% of its holdings in the Subsidiary to Intellisense, in exchange for consideration consisting of shares of Intellisense’s common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the closing of the Exchange Agreement (the “Closing”). The Closing occurred on December 30, 2019 (the “Closing Date”). On December 31, 2019, Intellisense changed its name to ScoutCam Inc.

 

Although the transaction resulted in the ScoutCam becoming a wholly owned subsidiary of Intellisense, the transaction constituted a reverse recapitalization since Medigus, the only shareholder of the ScoutCam prior to the Exchange Agreement, was issued a substantial majority of the outstanding capital stock of Intellisense upon consummation of the Exchange Agreement, and also taking into account that prior to the Closing Date, Intellisense was considered as a shell corporation. Accordingly, the Subsidiary is considered the accounting acquirer of the merged company.

 

The Subsidiary has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam™ 1.2. These innovative cameras are suitable for both medical and industrial applications. Based on its proprietary technology, The Subsidiary designs and manufactures endoscopy and micro camera systems for partner companies.

 

 

b.

 

The accompanying comparative consolidated financial statements include the historical accounts of the Subsidiary as a “Carve-out Business”, a division of Medigus. Throughout the comparative periods included in these Financial Statements, the Carve-out Business operated as part of Medigus. Separate financial statements have not historically been prepared for the Carve-out Business. These comparative carve-out financial data has been prepared on a standalone basis and is derived from Medigus’s consolidated financial statements and accounting records. The carve-out comparative financial data reflects the Subsidiary’s financial position, results of operations, changes in net parent deficit and cash flows in accordance with U.S. GAAP.

 

The financial position, results of operations, changes in net parent deficit, and cash flows of the Carve-out Business may not be indicative of its results had it been a separate stand-alone entity during the comparative periods presented.

 

The comparative carve-out financial data of the Company includes expenses which were allocated from Medigus for certain functions, including general corporate expenses related to corporate strategy, procurement, Information Technology (“IT”), Human Resources (“HR”) and legal. These allocation have been made on the basis of direct usage when identifiable, with the remainder allocated on the basis of headcount. Management believes the expense allocation methodology and results are reasonable and consistently applied for all comparative periods presented. However, these allocations may not be indicative of the actual expenses that would have been incurred by an independent company or of the costs to be incurred in the future.

 

The carve-out comparative financial statements include assets and liabilities specifically attributable to the Carve-out Business. Medigus uses a centralized approach for managing cash and financing operations. Accordingly, a substantial portion of the cash balances are transferred to Medigus’ cash management accounts regularly and therefore are not included in the financial statements. Transfers of cash between Carve-out business and Medigus are included within “Net transfers from Parent company” on the Statements of Cash Flows and the Statements of changes in shareholder’s equity (capital deficiency).

 

As the carve-out comparative financial information has been prepared on a carve-out basis, the amounts reflected in Parent Company deficit in the comparative statement of changes in shareholder’s equity (capital deficiency) refer to net loss for the period attributed to the Subsidiary in addition to transactions between Medigus and the Subsidiary.

     
  c. During the six month ended June 30, 2020, the Company incurred a loss of USD 2,383 thousand and negative cash flows from operating activities of approximately USD 2,277 thousand. Based on the projected cash flows, the Company’s Management is of the opinion that without further fundraising it will not have sufficient resources to enable it to continue its operating activities including the development, manufacturing and marketing of its products within one year after the issuance date of these financial statements. As a result, there is a substantial doubt about the Company’s ability to continue as a going concern within one year after the issuance date of these financial statements.
     
    Management’s plans include continuing commercialization of the Company’s products and securing sufficient financing through the sale of additional equity securities, debt or capital inflows from strategic partnerships and other opportunities. There are no assurances however, that the Company will be successful in obtaining the level of financing needed for its operations. If the Company is unsuccessful in commercializing its products and securing sufficient financing, it may need to reduce activities, curtail or even cease operations.
     
   

These consolidated financial statements have been prepared assuming the Company will continue as a going concern, which assumes the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly, the consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets and the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The accounting policies set out below have, unless otherwise stated, been applied consistently.

     
  d. The coronavirus (“COVID-19”), which was declared in March 2020 by the World Health Organization as a pandemic, has had a significant impact on global markets and the economy of many countries, including countries in which the Company operates. As the ultimate impact on the global economy of the COVID-19 pandemic remains unclear, the Company anticipates that it will have a continuing impact on global economies in the near future. While the COVID-19 pandemic has not materially affected the Company’s operations as of the date hereof, the extent to which the COVID-19 pandemic shall impact the Company’s operations will depend on future developments. In particular, the continued spread of COVID-19 globally could materially adversely impact the Company’s operations and workforce, including its manufacturing activities, product sales, as well as its ability to continue to raise capital. Travel restrictions could materially adversely impact our sales and marketing and research and development efforts.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Significant Accounting Policies
 6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Basis of Presentation and Significant Accounting Policies

NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

  A. Unaudited Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.

 

  B. Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

 

  C. Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.

 

  D. Significant Accounting Policies

 

The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.

 

  E. Recently Adopted Accounting Pronouncement

 

The significant accounting policies followed in the preparation of these unaudited interim consolidated financial statements are identical to those applied in the preparation of the latest annual audited financial statements with the exception of the following:

 

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments – Credit Losses” to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. The ASU replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. The Company adopted this ASU on January 1, 2020. There was not a material impact on the interim consolidated financial statements.

 

In August 2018, the FASB issued ASU 2018-13, “Changes to Disclosure Requirements for Fair Value Measurements,” which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements and is effective for the Company beginning on January 1, 2020. This standard did not have a material effect on the Company’s interim consolidated financial statements.

 

In November 2018, the FASB issued ASU 2018-18 – “Collaborative Arrangements (Topic 808),” which clarifies the interaction between Topic 808 and Topic 606, Revenue from Contracts with Customers. The Company adopted this standard in the first quarter of fiscal year 2020. This standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.

 

  F. Recent Accounting Pronouncements

 

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. The Company does not expect that the adoption of this standard will have a significant impact on the consolidated financial statements and related disclosures.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Leases
 6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Leases

NOTE 3 – LEASES:

 

On January 1, 2019, the Company adopted ASU 2016-02 using the modified retrospective approach for all lease arrangements at the beginning period of adoption. The Subsidiary leases office and vehicles under operating leases. On June 30, 2020, the Company’s ROU assets and lease liabilities for operating leases totalled $94 thousand.

 

In January 2020, the Subsidiary entered into a lease agreement for office space in Omer, Israel. The agreement is for 11 months beginning on February 1, 2020. Monthly lease payments under the agreement are approximately $6 thousand. Lease expenses recorded in the interim consolidated statements of operations were $31 thousand for the six months ended June 30, 2020. The Company has elected the short-term lease exception for this lease. As part of this election it will not recognize right-of-use assets and lease liabilities on the balance sheet for this lease.

 

Supplemental cash flow information related to operating leases was as follows:

 

   

Six months ended

June 30, 2020

  
    USD in thousands  
Cash payments for operating leases     23  
Cash payments for short-term lease     31  
Total lease expenses     54  

 

As of June 30, 2020, the Company’s operating leases had a weighted average remaining lease term of 1.9 years and a weighted average discount rate of 10%. Future lease payments under operating leases as of June 30, 2020 are as follows:

 

    Operating leases  
    USD in thousands  
Remainder of 2020     23  
2021     45  
2022     38  
Total future lease payments     106  
Less imputed interest     (12 )
Total lease liability balance     94  
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Equity
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Equity

NOTE 4 – EQUITY:

 

Private placement:

 

  a. In December 2019, the Company allotted in a private issuance, a total of 3,413,312 units at a purchase price of USD $0.968 per unit. Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below). The immediate proceeds (gross) from the issuance of the units amounted to approximately USD 3.3 million.

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 month period following the allotment. Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 month period following the allotment.

 

In addition, Shrem Zilberman Group Ltd. (the “Consultant”) will be entitled to receive the amount representing 3% of any exercise price of each Warrant A or Warrant B that may be exercised in the future. In the event the total proceeds received as a result of exercise of Warrants will be less than $2 million at the time of their expiration, the Consultant will be required to invest $250,000 in the Company in return for shares of common stock of Company.

 

  b. On March 3, 2020, the Company allotted in a private issuance a total of 979,754 units at a purchase price of USD $0.968 per unit.

 

Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below).

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 month period following the allotment.

 

Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 month period following the allotment.

 

The immediate proceeds (gross) from the issuance of all securities offered amounted to approximately USD 948 thousands. After deducting closing costs and fees, the Company received proceeds of approximately USD 909 thousand, net of issuance expenses.

 

  c. On May 18, 2020, the Company allotted in a private issuance a total of 2,066,116 units at a purchase price of USD $0.968 per unit.

 

Each unit was comprised of two shares of common stock par value US$0.001 per share, one Warrant A (defined below) and two Warrants B (defined below).

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 18 month period following the allotment.

 

Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 24 month period following the allotment.

 

The immediate proceeds (gross) from the issuance of all securities offered amounted to approximately USD 2 million. After deducting closing costs and fees, the Company received proceeds of approximately USD 1.9 million, net of issuance expenses.

 

  d.

On June 23, 2020, (the “Conversion Date”) the Company entered into and consummated a Side Letter Agreement with Medigus, whereby the parties agreed to convert, at a conversion price of $0.484, an outstanding line of credit previously extended by Medigus to the Subsidiary, which as of the Conversion Date was $381,136, into (a) 787,471 shares of the Company’s common stock, (b) warrants to purchase 393,736 shares of common stock with an exercise price of $0.595 (Warrant A), and (c) warrants to purchase 787,471 shares of common stock with an exercise price of $0.893 (Warrant B).

 

Each Warrant A is exercisable into one share of common stock of the Company at an exercise price of USD 0.595 per share during the 12 months period following the allotment.

 

Each Warrant B is exercisable into one share of common stock of the Company at an exercise price of USD 0.893 per share during the 18 months period following the allotment. 

 

 

As of June 30, 2020, the Company had the following outstanding warrants to purchase Common Stock as follows:

 

Warrant   Issuance Date   Expiration Date   Exercise Price Per Share ($)     Number of Shares of Common Stock Underlying Warrants  
Warrant A   December 30, 2019   December 30, 2020     0.595       3,413,317  
Warrant B   December 30, 2019   June 30, 2021     0.893       6,826,623  
Warrant A   March 3, 2020   March 3, 2021     0.595       979,754  
Warrant B   March 3, 2020   September 3, 2021     0.893       1,959,504  
Warrant A   May 18, 2020   November 18, 2021     0.595       2,066,116  
Warrant B   May 18 2020   May 18, 2022     0.893       4,132,232  
Warrant A   June 23, 2020   June 23, 2021     0.595       393,736  
Warrant B   June 23,2020   December 23, 2021     0.893       787,471  
                      20,558,753  

 

Share-based compensation to employees and to directors:

 

In February 2020, the Company’s Board of Directors approved the 2020 Share Incentive Plan (the “Plan”). The Plan initially included a pool of 5,228,007 shares of common stock for grant to Company employees, consultants, directors, and other service providers. On March 15, 2020, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 576,888 shares of Common Stock. On June 22, 2020, the Company’s Board of Directors approved an increase to the Company’s option pool pursuant to the Plan by an additional 3,617,545 shares of Common Stock.

 

The Plan is designed to enable the Company to grant options to purchase ordinary shares and RSUs under various and different tax regimes including, without limitation: (i) pursuant and subject to Section 102 of the Israeli Tax Ordinance or any provision which may amend or replace it and any regulations, rules, orders or procedures promulgated thereunder and to designate them as either grants made through a trustee or not through a trustee; and (ii) pursuant and subject to Section 3(i) of the Israeli Tax Ordinance.

 

On February 12, 2020, the Company granted 4,367,515 options pursuant to the Plan. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.

 

On March 15, 2020, the Company granted 576,888 options pursuant to the Plan to each of the Company’s then serving directors, excluding Professor Benad Goldwasser. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.

 

On June 22, 2020, the Company granted 1,544,769 options pursuant to the Plan to Company employees, consultants, directors. Each option is convertible into one share of common stock of the Company of $0.001 par value at the exercise price of $0.29.

 

The fair value of each option was estimated as of the grant date or reporting period using the Black-Scholes option-pricing model, using the following assumptions:

 

   

Six months ended

June 30, 2020

  
Underlying value of ordinary shares ($)     0.475  
Exercise price ($)     0.29  
Expected volatility (%)     43.91  
Term of the options (years)     7  
Risk-free interest rate (%)     1.25  

 

The cost of the benefit embodied in the options granted during the six months ended June 30, 2020, based on their fair value as at the grant date, is estimated to be approximately $3.3 million. These amounts will be recognized in statements of operations over the vesting period.

 

The following table summarizes stock option activity for the six months ended June 30, 2020:

 

   

For the

Six months ended

June 30, 2020

  
    Amount of options     Weighted average exercise price  
              $  
Outstanding at beginning of period     -       -  
Granted     6,489,172       0.29  
Outstanding at end of period     6,489,172       0.29  
                 
Vested at end of period     1,203,237       0.29  

 

The following table sets forth the total share-based payment expenses resulting from options granted, included in the statements of operation:

 

   

Six months ended

June 30, 2020

  
    USD in thousands  
Research and development     120  
General and administrative     717  
Total expenses     837  
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Revenues
 6 Months Ended
Jun. 30, 2020
Revenue from Contract with Customer [Abstract]  
Revenues

NOTE 5 – REVENUES:

 

Contract liabilities: 

 

The Company’s contract liabilities as of June 30, 2020 and December 31, 2019 were as follows:

 

    June 30,     December 31,  
    2020     2019  
    USD in thousands  
Contract liabilities     672       502  
                 

 

Contract liabilities include advance payments, which are primarily related to advanced billings for development services.

 

Remaining Performance Obligations

 

Remaining Performance Obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of June 30, 2020, the total RPO amounted to $900 thousand, which the Company expects to recognize during the next 12 months.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory
 6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Inventory

NOTE 6 – INVENTORY

 

Composed as follows:

 

    June 30,     December 31,  
    2020     2019  
    USD in thousands  
Raw materials and supplies     20       24  
Work in progress     647       316  
Finished goods     572       560  
      1,239       900  

 

During the period ended June 30, 2020, no impairment occurred.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Loss Per Share
 6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Loss Per Share

NOTE 7 – LOSS PER SHARE

 

Basic loss per share is computed by dividing net loss attributable to ordinary shareholders of the Company, by the weighted average number of ordinary shares as described below.

 

In computing the Company’s diluted loss per share, the numerator used in the basic loss per share computation is adjusted for the dilutive effect, if any, of the Company’s potential shares of common stock. The denominator for diluted loss per share is a computation of the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period.

 

The loss per share information in these consolidated financial statements is reflected and calculated as if the Company had existed since January 1, 2019. Accordingly, loss per share for all periods was calculated based on the number of shares retroactively adjusted for the exchange ratio determined in the reverse recapitalization.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Related Parties
 6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Related Parties

NOTE 8 – RELATED PARTIES

 

On May 30, 2019, the Subsidiary entered into an intercompany agreement with Medigus (the “Intercompany Agreement”) according to which the Subsidiary agreed to hire and retain certain services from Medigus. The agreed upon services provided under the Intercompany Agreement included: (1) lease of office space and clean room based on actual space utilized by the Subsidiary and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (4) external accountant services at a price of USD 6,000 per annum; (5) directors and officers insurance at a sum of 1/3 of Parent company cost; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (8) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense

 

In addition, the Subsidiary’s employees provide support services to Medigus.

 

On April 20, 2020, the Subsidiary entered into an amended and restated intercompany services agreement with Medigus. The agreed upon services provided under the amended and restated Intercompany Agreement included:

 

1) lease of office space based on actual space utilized by the Parent Company and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (5) directors and officers insurance the Parent Company shall pay $150,000 of the annual premium.; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (7) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense

 

Balances with related parties:

 

    June 30, 2020     December 31, 2019  
             
Parent Company     143       73  
Loan from Parent Company (see note 4(d))     -       500  

 

Transactions with related parties:

 

    Six months ended June 30,  
    2020     2019  
Revenues     5       -  
Cost of revenues     5       -  
Interest payments     8       -  
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
 6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

NOTE 9 - SUBSEQUENT EVENTS

 

In accordance with ASC 855 “Subsequent Events” the Company evaluated subsequent events through the date the condensed consolidated financial statements were issued. The Company concluded that no subsequent events have occurred that would require recognition or disclosure in the condensed consolidated financial statements.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Basis of Presentation and Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Unaudited Interim Financial Statements
  A. Unaudited Interim Financial Statements

 

The accompanying unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of U.S. Securities and Exchange Commission Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included (consisting only of normal recurring adjustments except as otherwise discussed). For further information, reference is made to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019.
Principles of Consolidation
  B. Principles of Consolidation

 

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
  C. Use of estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.
Significant Accounting Policies
  D. Significant Accounting Policies

 

The significant accounting policies followed in the preparation of these unaudited interim condensed consolidated financial statements are identical to those applied in the preparation of the latest annual financial statements.
Recently Adopted Accounting Pronouncement
  E. Recently Adopted Accounting Pronouncement

 

The significant accounting policies followed in the preparation of these unaudited interim consolidated financial statements are identical to those applied in the preparation of the latest annual audited financial statements with the exception of the following:

 

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments – Credit Losses” to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. The ASU replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. The Company adopted this ASU on January 1, 2020. There was not a material impact on the interim consolidated financial statements.

 

In August 2018, the FASB issued ASU 2018-13, “Changes to Disclosure Requirements for Fair Value Measurements,” which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements and is effective for the Company beginning on January 1, 2020. This standard did not have a material effect on the Company’s interim consolidated financial statements.

 

In November 2018, the FASB issued ASU 2018-18 – “Collaborative Arrangements (Topic 808),” which clarifies the interaction between Topic 808 and Topic 606, Revenue from Contracts with Customers. The Company adopted this standard in the first quarter of fiscal year 2020. This standard did not have a material impact on the Company’s consolidated financial statements and related disclosures.
Recent Accounting Pronouncements
  F. Recent Accounting Pronouncements

 

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for the Company beginning on January 1, 2021, with early adoption permitted. The Company does not expect that the adoption of this standard will have a significant impact on the consolidated financial statements and related disclosures.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Leases (Tables)
 6 Months Ended
Jun. 30, 2020
Leases [Abstract]  
Schedule of Supplemental Cash Flow Information Related to Operating Leases

Supplemental cash flow information related to operating leases was as follows:

 

   

Six months ended

June 30, 2020

  
    USD in thousands  
Cash payments for operating leases     23  
Cash payments for short-term lease     31  
Total lease expenses     54  
Schedule of Maturities Lease Liabilities Under Operating Leases

Future lease payments under operating leases as of June 30, 2020 are as follows:

 

    Operating leases  
    USD in thousands  
Remainder of 2020     23  
2021     45  
2022     38  
Total future lease payments     106  
Less imputed interest     (12 )
Total lease liability balance     94  
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Equity (Tables)
 6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of Stock Warrants Outstanding to Purchase Common Stock

As of June 30, 2020, the Company had the following outstanding warrants to purchase Common Stock as follows:

 

Warrant   Issuance Date   Expiration Date   Exercise Price Per Share ($)     Number of Shares of Common Stock Underlying Warrants  
Warrant A   December 30, 2019   December 30, 2020     0.595       3,413,317  
Warrant B   December 30, 2019   June 30, 2021     0.893       6,826,623  
Warrant A   March 3, 2020   March 3, 2021     0.595       979,754  
Warrant B   March 3, 2020   September 3, 2021     0.893       1,959,504  
Warrant A   May 18, 2020   November 18, 2021     0.595       2,066,116  
Warrant B   May 18 2020   May 18, 2022     0.893       4,132,232  
Warrant A   June 23, 2020   June 23, 2021     0.595       393,736  
Warrant B   June 23,2020   December 23, 2021     0.893       787,471  
                      20,558,753  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The fair value of each option was estimated as of the grant date or reporting period using the Black-Scholes option-pricing model, using the following assumptions:

 

   

Six months ended

June 30, 2020

  
Underlying value of ordinary shares ($)     0.475  
Exercise price ($)     0.29  
Expected volatility (%)     43.91  
Term of the options (years)     7  
Risk-free interest rate (%)     1.25  
Schedule of Stock Options Activity

The following table summarizes stock option activity for the six months ended June 30, 2020:

 

    For the
Six months ended
June 30, 2020		  
    Amount of options     Weighted average exercise price  
              $  
Outstanding at beginning of period     -       -  
Granted     6,489,172       0.29  
Outstanding at end of period     6,489,172       0.29  
                 
Vested at end of period     1,203,237       0.29  
Schedule of Total Share-based Payment Expenses

The following table sets forth the total share-based payment expenses resulting from options granted, included in the statements of operation:

 

   

Six months ended

June 30, 2020

  
    USD in thousands  
Research and development     120  
General and administrative     717  
Total expenses     837  
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Revenues (Tables)
 6 Months Ended
Jun. 30, 2020
Revenue from Contract with Customer [Abstract]  
Schedule of Contract Liabilities

The Company’s contract liabilities as of June 30, 2020 and December 31, 2019 were as follows:

 

    June 30,     December 31,  
    2020     2019  
    USD in thousands  
Contract liabilities     672       502  
                 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory (Tables)
 6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventory

Composed as follows:

 

    June 30,     December 31,  
    2020     2019  
    USD in thousands  
Raw materials and supplies     20       24  
Work in progress     647       316  
Finished goods     572       560  
      1,239       900  
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Related Parties (Tables)
 6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Schedule of Balances with Related Parties

Balances with related parties:

 

    June 30, 2020     December 31, 2019  
             
Parent Company     143       73  
Loan from Parent Company (see note 4(d))     -       500  
Schedule of Related Party Transactions

Transactions with related parties:

 

    Six months ended June 30,  
    2020     2019  
Revenues     5       -  
Cost of revenues     5       -  
Interest payments     8       -  
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.20.2
General (Details Narrative) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 16, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Mar. 31, 2019
Mar. 22, 2013
State country code       NV        
Date of incorporation       Mar. 22, 2013        
Common stock, shares issued   33,764,128   33,764,128   26,884,921    
Net loss   $ (970) $ (362) $ (2,383) $ (691)      
Net cash used in operating activities   $ (1,140) $ (385) $ (2,277) $ (899)      
Medigus Ltd [Member]                
Common stock, shares issued             1,000,000 1,000,000
Common stock, par value            
ScoutCam Ltd., [Member] | Securities Exchange Agreement [Member]                
Equity ownership percentage 100.00%              
Exchange agreement description On September 16, 2019, Intellisense entered into a Securities Exchange Agreement (the "Exchange Agreement"), with Medigus, pursuant to which Medigus assigned, transferred and delivered 100% of its holdings in ScoutCam to Intellisense, in exchange for consideration consisting of shares of Intellisense's common stock representing 60% of the issued and outstanding share capital of Intellisense immediately upon the closing of the Exchange Agreement (the "Closing"). The Closing occurred on December 30, 2019 (the "Closing Date").              
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Leases (Details Narrative) - USD ($)
$ in Thousands
 1 Months Ended 6 Months Ended
Jan. 31, 2020
Jun. 30, 2020
Dec. 31, 2019
Operating lease right-of-use assets   $ 94 $ 53
Monthly lease, payments   23  
Lease expenses   $ 54  
Weighted average remaining lease term   1 year 10 months 25 days  
Weighted average discount rate   10.00%  
Lease Agreement [Member]      
Lease description   In January 2020, the Subsidiary entered into a lease agreement for office space in Omer, Israel. The agreement is for 11 months beginning on February 1, 2020. Monthly lease payments under the agreement are approximately $6 thousand. Lease expenses recorded in the interim consolidated statements of operations were $31 thousand for the six months ended June 30, 2020.  
Monthly lease, payments $ 6    
Lease expenses   $ 31  
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
USD ($)
Leases [Abstract]  
Cash payments for operating leases $ 23
Cash payments for short-term lease 31
Total lease expenses $ 54
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Leases - Schedule of Maturities Lease Liabilities Under Operating Leases (Details)
$ in Thousands
Jun. 30, 2020
USD ($)
Leases [Abstract]  
Remainder of 2020 $ 23
2021 45
2022 38
Total future lease payments 106
Less imputed interest (12)
Total lease liability balance $ 94
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Jun. 23, 2020
Jun. 22, 2020
May 18, 2020
Mar. 15, 2020
Mar. 03, 2020
Feb. 12, 2020
Feb. 29, 2020
Dec. 31, 2019
Jun. 30, 2020
Allotted in private issuance               3,413,312  
Shares issued price per share               $ 0.968  
Number of common stock               2  
Common stock par value               $ 0.001 $ 0.001
Proceeds from issuance of common stock                 $ 3,300
Share-based compensation granted shares                 6,489,172
Share-based compensation vested in period, fair value                 $ 3,300
2020 Share Incentive Plan [Member]                  
Number of common stock   1   1   1      
Common stock par value   $ 0.001   $ 0.001   $ 0.001      
Share-based compensation granted shares   1,544,769   576,888   4,367,515      
Stock option, exercise price   $ 0.29   $ 0.29   $ 0.29      
Letter Agreement [Member] | Medigus Ltd [Member]                  
Convertible conversion price $ 0.484                
Consultant [Member]                  
Warrant exercise price percentage                 3.00%
Proceeds from exercise of warrant                 $ 2,000
Number of common stock value                 $ 250
Employees, Consultants, Directors and Other Service Providers [Member] | 2020 Share Incentive Plan [Member]                  
Share-based compensation granted shares             5,228,007    
Board of Directors [Member] | 2020 Share Incentive Plan [Member]                  
Share-based compensation granted shares   3,617,545   576,888          
Each Warrant A [Member]                  
Number of warrants 1   0.001           1
Warrants exercise price $ 0.595   $ 0.595           $ 0.595
Warrant term 12 months   18 months           12 months
Each Warrant B [Member]                  
Number of warrants 1   1           1
Warrants exercise price $ 0.893   $ 0.893           $ 0.893
Warrant term 18 months   24 months           18 months
Warrant [Member]                  
Allotted in private issuance     2,066,116   979,754        
Shares issued price per share     $ 0.968   $ 0.968        
Common stock par value     $ 0.001   $ 0.001        
Proceeds from issuance of common stock     $ 2,000   $ 948        
Proceeds from issuance of shares net of issuance expense     $ 1,900   $ 909        
Warrant [Member] | Letter Agreement [Member] | Medigus Ltd [Member]                  
Number of warrants 393,736                
Warrants exercise price $ 0.595                
Warrant A [Member]                  
Number of warrants         1        
Warrants exercise price         $ 0.595       $ 0.595
Warrant term         12 months        
Warrant B [Member]                  
Number of warrants         1        
Warrants exercise price         $ 0.893       $ 0.893
Warrant term         18 months        
Ordinary Shares [Member] | Letter Agreement [Member] | Medigus Ltd [Member]                  
Conversion Convertible debt $ 381,136                
Convert conversion 787,471                
Warrant One [Member] | Letter Agreement [Member] | Medigus Ltd [Member]                  
Number of warrants 787,471                
Warrants exercise price $ 0.893                
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Equity - Schedule of Stock Warrants Outstanding to Purchase Common Stock (Details) - $ / shares
 6 Months Ended
Jun. 30, 2020
Mar. 03, 2020
Warrant A [Member]    
Warrant, Issuance Date Dec. 30, 2019  
Warrant, Expiration Date Dec. 30, 2020  
Warrant, Exercise Price Per Share $ 0.595 $ 0.595
Warrant, Number of Shares of Common Stock Underlying Warrants 3,413,317  
Warrant B [Member]    
Warrant, Issuance Date Dec. 30, 2019  
Warrant, Expiration Date Jun. 30, 2021  
Warrant, Exercise Price Per Share $ 0.893 $ 0.893
Warrant, Number of Shares of Common Stock Underlying Warrants 6,826,623  
Warrant A One [Member]    
Warrant, Issuance Date Mar. 03, 2020  
Warrant, Expiration Date Mar. 03, 2021  
Warrant, Exercise Price Per Share $ 0.595  
Warrant, Number of Shares of Common Stock Underlying Warrants 979,754  
Warrant B One [Member]    
Warrant, Issuance Date Mar. 03, 2020  
Warrant, Expiration Date Sep. 03, 2021  
Warrant, Exercise Price Per Share $ 0.893  
Warrant, Number of Shares of Common Stock Underlying Warrants 1,959,504  
Warrant A Two [Member]    
Warrant, Issuance Date May 18, 2020  
Warrant, Expiration Date Nov. 18, 2021  
Warrant, Exercise Price Per Share $ 0.595  
Warrant, Number of Shares of Common Stock Underlying Warrants 2,066,116  
Warrant B Two [Member]    
Warrant, Issuance Date May 18, 2020  
Warrant, Expiration Date May 18, 2022  
Warrant, Exercise Price Per Share $ 0.893  
Warrant, Number of Shares of Common Stock Underlying Warrants 4,132,232  
Warrant A Three [Member]    
Warrant, Issuance Date Jun. 23, 2020  
Warrant, Expiration Date Jun. 23, 2021  
Warrant, Exercise Price Per Share $ 0.595  
Warrant, Number of Shares of Common Stock Underlying Warrants 393,736  
Warrant B Three [Member]    
Warrant, Issuance Date Jun. 23, 2020  
Warrant, Expiration Date Dec. 23, 2021  
Warrant, Exercise Price Per Share $ 0.893  
Warrant, Number of Shares of Common Stock Underlying Warrants 787,471  
Warrant [Member]    
Warrant, Number of Shares of Common Stock Underlying Warrants 20,558,753  
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Equity - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)
 6 Months Ended
Jun. 30, 2020
$ / shares
Equity [Abstract]  
Underlying value of ordinary shares $ 0.475
Exercise price $ 0.29
Expected volatility 43.91%
Term of the options (years) 7 years
Risk-free interest rate 1.25%
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Equity - Schedule of Stock Options Activity (Details)
 6 Months Ended
Jun. 30, 2020
$ / shares
shares
Equity [Abstract]  
Options, Outstanding at beginning of period | shares
Options, Granted | shares 6,489,172
Options, Outstanding at end of period | shares 6,489,172
Options, Vested at end of period | shares 1,203,237
Weighted average exercise price, Outstanding at beginning of period | $ / shares
Weighted average exercise price, Granted | $ / shares 0.29
Weighted average exercise price, Outstanding at end of period | $ / shares 0.29
Weighted average exercise price, Vested at end of period | $ / shares $ 0.29
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Equity - Schedule of Total Share-based Payment Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Total expenses $ 155 $ 837
Research and Development [Member]        
Total expenses     120  
General and Administrative [Member]        
Total expenses     $ 717  
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Revenues (Details Narrative)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
USD ($)
Revenue from Contract with Customer [Abstract]  
Remaining performance obligations $ 900
Revenue remaining performance obligation expected period description The Company expects to recognize during the next 12 months.
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Revenues - Schedule of Contract Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Contract liabilities $ 672 $ 502
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory (Details Narrative)
 6 Months Ended
Jun. 30, 2020
USD ($)
Inventory Disclosure [Abstract]  
Impairment occurred
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Inventory - Schedule of Inventory (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 20 $ 24
Work in progress 647 316
Finished goods 572 560
Inventory net $ 1,239 $ 900
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Related Parties (Details Narrative) - Medigus Ltd [Member]
Apr. 20, 2020
May 30, 2019
Intercompany Agreement [Member]    
Intercompany agreement description   The agreed upon services provided under the Intercompany Agreement included: (1) lease of office space and clean room based on actual space utilized by the Subsidiary and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (4) external accountant services at a price of USD 6,000 per annum; (5) directors and officers insurance at a sum of 1/3 of Parent company cost; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (8) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense
Amended and Restated Intercompany Services Agreement [Member]    
Intercompany agreement description The agreed upon services provided under the amended and restated Intercompany Agreement included: 1) lease of office space based on actual space utilized by the Parent Company and in shared spaces according to employee ratio; (2) utilities such as electricity water, IT and communication services based on employee ratio; (3) car services, including car rental, gas usage, payment for toll roads based on 100% of expense incurred from a Subsidiary employee car; (5) directors and officers insurance the Parent Company shall pay $150,000 of the annual premium.; (6) CFO services at a sum of 50% of Parent company CFO employer cost; (7) every direct expense of the Subsidiary that is paid by the Parent company in its entirety subject to approval of such direct expenses in advance; and (7) any other mutual expense that is borne by the parties according to the Respective portion of the Mutual Expense  
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Related Parties - Schedule of Balances with Related Parties (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Related Party Transactions [Abstract]    
Parent Company $ 143 $ 73
Loan from Parent Company (see note 4(d)) $ 500
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Related Parties - Schedule of Related Party Transactions (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues $ 34 $ 120 $ 74 $ 144
Cost of revenues $ 151 $ 195 281 304
Related Parties [Member]        
Revenues     5
Cost of revenues     5
Interest payments     $ 8
EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 109 253 1 false 32 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://Scoutcam.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Interim Condensed Consolidated Balance Sheets Sheet http://Scoutcam.com/role/InterimCondensedConsolidatedBalanceSheets Interim Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Interim Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://Scoutcam.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical Interim Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://Scoutcam.com/role/InterimCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Sheet http://Scoutcam.com/role/InterimCondensedConsolidatedStatementsOfChangesInShareholdersEquity Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Interim Condensed Conolidated Statements of Cash Flows (Unaudited) Sheet http://Scoutcam.com/role/InterimCondensedConolidatedStatementsOfCashFlows Interim Condensed Conolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - General Sheet http://Scoutcam.com/role/General General Notes 7 false false R8.htm 00000008 - Disclosure - Basis of Presentation and Significant Accounting Policies Sheet http://Scoutcam.com/role/BasisOfPresentationAndSignificantAccountingPolicies Basis of Presentation and Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Leases Sheet http://Scoutcam.com/role/Leases Leases Notes 9 false false R10.htm 00000010 - Disclosure - Equity Sheet http://Scoutcam.com/role/Equity Equity Notes 10 false false R11.htm 00000011 - Disclosure - Revenues Sheet http://Scoutcam.com/role/Revenues Revenues Notes 11 false false R12.htm 00000012 - Disclosure - Inventory Sheet http://Scoutcam.com/role/Inventory Inventory Notes 12 false false R13.htm 00000013 - Disclosure - Loss Per Share Sheet http://Scoutcam.com/role/LossPerShare Loss Per Share Notes 13 false false R14.htm 00000014 - Disclosure - Related Parties Sheet http://Scoutcam.com/role/RelatedParties Related Parties Notes 14 false false R15.htm 00000015 - Disclosure - Subsequent Events Sheet http://Scoutcam.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 00000016 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) Sheet http://Scoutcam.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies Basis of Presentation and Significant Accounting Policies (Policies) Policies http://Scoutcam.com/role/BasisOfPresentationAndSignificantAccountingPolicies 16 false false R17.htm 00000017 - Disclosure - Leases (Tables) Sheet http://Scoutcam.com/role/LeasesTables Leases (Tables) Tables http://Scoutcam.com/role/Leases 17 false false R18.htm 00000018 - Disclosure - Equity (Tables) Sheet http://Scoutcam.com/role/EquityTables Equity (Tables) Tables http://Scoutcam.com/role/Equity 18 false false R19.htm 00000019 - Disclosure - Revenues (Tables) Sheet http://Scoutcam.com/role/RevenuesTables Revenues (Tables) Tables http://Scoutcam.com/role/Revenues 19 false false R20.htm 00000020 - Disclosure - Inventory (Tables) Sheet http://Scoutcam.com/role/InventoryTables Inventory (Tables) Tables http://Scoutcam.com/role/Inventory 20 false false R21.htm 00000021 - Disclosure - Related Parties (Tables) Sheet http://Scoutcam.com/role/RelatedPartiesTables Related Parties (Tables) Tables http://Scoutcam.com/role/RelatedParties 21 false false R22.htm 00000022 - Disclosure - General (Details Narrative) Sheet http://Scoutcam.com/role/GeneralDetailsNarrative General (Details Narrative) Details http://Scoutcam.com/role/General 22 false false R23.htm 00000023 - Disclosure - Leases (Details Narrative) Sheet http://Scoutcam.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://Scoutcam.com/role/LeasesTables 23 false false R24.htm 00000024 - Disclosure - Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) Sheet http://Scoutcam.com/role/Leases-ScheduleOfSupplementalCashFlowInformationRelatedToOperatingLeasesDetails Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) Details 24 false false R25.htm 00000025 - Disclosure - Leases - Schedule of Maturities Lease Liabilities Under Operating Leases (Details) Sheet http://Scoutcam.com/role/Leases-ScheduleOfMaturitiesLeaseLiabilitiesUnderOperatingLeasesDetails Leases - Schedule of Maturities Lease Liabilities Under Operating Leases (Details) Details 25 false false R26.htm 00000026 - Disclosure - Equity (Details Narrative) Sheet http://Scoutcam.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://Scoutcam.com/role/EquityTables 26 false false R27.htm 00000027 - Disclosure - Equity - Schedule of Stock Warrants Outstanding to Purchase Common Stock (Details) Sheet http://Scoutcam.com/role/Equity-ScheduleOfStockWarrantsOutstandingToPurchaseCommonStockDetails Equity - Schedule of Stock Warrants Outstanding to Purchase Common Stock (Details) Details 27 false false R28.htm 00000028 - Disclosure - Equity - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) Sheet http://Scoutcam.com/role/Equity-ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails Equity - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) Details 28 false false R29.htm 00000029 - Disclosure - Equity - Schedule of Stock Options Activity (Details) Sheet http://Scoutcam.com/role/Equity-ScheduleOfStockOptionsActivityDetails Equity - Schedule of Stock Options Activity (Details) Details 29 false false R30.htm 00000030 - Disclosure - Equity - Schedule of Total Share-based Payment Expenses (Details) Sheet http://Scoutcam.com/role/Equity-ScheduleOfTotalShare-basedPaymentExpensesDetails Equity - Schedule of Total Share-based Payment Expenses (Details) Details 30 false false R31.htm 00000031 - Disclosure - Revenues (Details Narrative) Sheet http://Scoutcam.com/role/RevenuesDetailsNarrative Revenues (Details Narrative) Details http://Scoutcam.com/role/RevenuesTables 31 false false R32.htm 00000032 - Disclosure - Revenues - Schedule of Contract Liabilities (Details) Sheet http://Scoutcam.com/role/Revenues-ScheduleOfContractLiabilitiesDetails Revenues - Schedule of Contract Liabilities (Details) Details 32 false false R33.htm 00000033 - Disclosure - Inventory (Details Narrative) Sheet http://Scoutcam.com/role/InventoryDetailsNarrative Inventory (Details Narrative) Details http://Scoutcam.com/role/InventoryTables 33 false false R34.htm 00000034 - Disclosure - Inventory - Schedule of Inventory (Details) Sheet http://Scoutcam.com/role/Inventory-ScheduleOfInventoryDetails Inventory - Schedule of Inventory (Details) Details 34 false false R35.htm 00000035 - Disclosure - Related Parties (Details Narrative) Sheet http://Scoutcam.com/role/RelatedPartiesDetailsNarrative Related Parties (Details Narrative) Details http://Scoutcam.com/role/RelatedPartiesTables 35 false false R36.htm 00000036 - Disclosure - Related Parties - Schedule of Balances with Related Parties (Details) Sheet http://Scoutcam.com/role/RelatedParties-ScheduleOfBalancesWithRelatedPartiesDetails Related Parties - Schedule of Balances with Related Parties (Details) Details 36 false false R37.htm 00000037 - Disclosure - Related Parties - Schedule of Related Party Transactions (Details) Sheet http://Scoutcam.com/role/RelatedParties-ScheduleOfRelatedPartyTransactionsDetails Related Parties - Schedule of Related Party Transactions (Details) Details 37 false false All Reports Book All Reports sctc-20200630.xml sctc-20200630.xsd sctc-20200630_cal.xml sctc-20200630_def.xml sctc-20200630_lab.xml sctc-20200630_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true ZIP 54 0001493152-20-015308-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-015308-xbrl.zip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b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�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end